{"content":"<li class=\"n-box-item date-title\" data-end=\"1570766399\" data-start=\"1570680000\" data-txt=\"Monday, December 23, 2019\">Thursday, October 10, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3505177\" data-ts=\"1570755545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAP\" target=\"_blank\">SAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505177-sap-se-eps-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAP SE EPS beats by \u20ac0.11, beats on revenue</a></h4><ul><li>SAP SE (NYSE:<a href='https://seekingalpha.com/symbol/SAP' title='SAP SE'>SAP</a>): Q3 Non-GAAP EPS of \u20ac1.30 <font color=\"green\">beats by \u20ac0.11</font>; GAAP EPS of \u20ac1.04 <font color=\"green\">beats by \u20ac0.19</font>.</li><li>Revenue of \u20ac6.81B (+12.9% Y/Y) <font color=\"green\">beats by \u20ac140M</font>.</li><li>Shares <font color=\"green\">+5.9%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17660067-sap-pre-announces-outstanding-third-quarter-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3505177\" data-linked=\"SAP SE EPS beats by \u20ac0.11, beats on revenue\" data-tweet=\"$SAP - SAP SE EPS beats by \u20ac0.11, beats on revenue https://seekingalpha.com/news/3505177-sap-se-eps-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3505177-sap-se-eps-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505171\" data-ts=\"1570748289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAP\" target=\"_blank\">SAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505171-sap-ceo-mcdermott-to-depart-pre-announces-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAP CEO McDermott to depart; pre-announces Q3 results</a></h4><ul><li><a href='https://seekingalpha.com/symbol/SAP' title='SAP SE'>SAP</a> says Bill McDermott is <a href=\"https://www.cnbc.com/2019/10/10/sao-ceo-bill-mcdermott-to-step-down.html\" target=\"_blank\">stepping down as CEO</a> after nine years running the company, and board members Jennifer Morgan and Christian Klein are co-CEOs, effective immediately.</li><li>The news coincides with the release of preliminary <a href=\"https://seekingalpha.com/pr/17660067-sap-pre-announces-outstanding-third-quarter-results\" target=\"_blank\">Q3 results</a> that showed new cloud bookings rising 38% Y/Y (33% at constant currencies) and 50% when excluding Infrastructure-as-a-Service.</li><li>The company says a \"cloud deal with a major partner\" accounted for  17 percentage points of new Q3 cloud bookings, and it will start recognizing revenue from the three-year deal in Q4.</li><li>SAP says Q3 cloud revenue jumped 37% Y/Y to \u20ac1.79B IFRS, 37% non-IFRS and 33% (non-IFRS at constant currencies); cloud gross margin rose 5.9 percentage points Y/Y to  64.5% IFRS, 5.4 percentage points to  69.0% non-IFRS and 5.5 percentage points to 69.0% non-IFRS at constant currencies.</li><li>Q3 earnings per share increased 28% to \u20ac1.04 IFRS and 14% to \u20ac1.30 non-IFRS; operating profit rose 36% to \u20ac1.68B IFRS, 20% non-IFRS and 15% non-IFRS at constant currencies.</li><li>SAP <font color=\"green\">+3.2%</font> after-hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505171\" data-linked=\"SAP CEO McDermott to depart; pre-announces Q3 results\" data-tweet=\"$SAP - SAP CEO McDermott to depart; pre-announces Q3 results https://seekingalpha.com/news/3505171-sap-ceo-mcdermott-to-depart-pre-announces-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3505171-sap-ceo-mcdermott-to-depart-pre-announces-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505169\" data-ts=\"1570746563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505169-tilrayplus-3_2-ab-jv-plans-to-commercialize-cbd-beverages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilray +3.2% as its AB JV plans to commercialize CBD beverages</a></h4><ul>   <li>Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) is <font color=\"green\">up 3.2%</font> in postmarket trading after the news that its joint venture with Anheuser-Busch InBev (NYSE:<a href='https://seekingalpha.com/symbol/BUD' title='Anheuser-Busch InBev SA/NV'>BUD</a>) will <a href=\"https://seekingalpha.com/pr/17659945-fluent-beverage-company-announces-plans-commercialize-non-alcohol-cbd-infused-beverages\" target=\"_blank\">commercialize CBD-infused beverages</a> in Canada, when legal.</li>    <li>The JV, Fluent Beverage Co., will make non-alcoholic CBD beverages with contributions from Tilray's High Park Co. and AB's Labatt Breweries.</li>    <li>Fluent wants to have the beverages available for sale as soon as December, depending on regulatory timelines implemented by Health Canada and provincial officials.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505169\" data-linked=\"Tilray +3.2% as its AB JV plans to commercialize CBD beverages\" data-tweet=\"$TLRY $BUD - Tilray +3.2% as its AB JV plans to commercialize CBD beverages https://seekingalpha.com/news/3505169-tilrayplus-3_2-ab-jv-plans-to-commercialize-cbd-beverages?source=tweet\" data-url=\"https://seekingalpha.com/news/3505169-tilrayplus-3_2-ab-jv-plans-to-commercialize-cbd-beverages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505167\" data-ts=\"1570745323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURG\" target=\"_blank\">BURG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505167-hooters-parent-shifts-cancer-research-via-reverse-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hooters parent shifts into cancer research via reverse merger</a></h4><ul>   <li>Hooters operator Chanticleer Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BURG' title='Chanticleer Holdings, Inc.'>BURG</a>) is shifting from restaurants to cancer drugs, <a href=\"https://seekingalpha.com/pr/17659857-chanticleer-holdings-announces-merger-agreement-sonnet-biotherapeutics-advance-pipeline-novel\" target=\"_blank\">planning a reverse merger</a> with privately held Sonnet BioTherapeutics.</li>    <li>Chanticleer shares are <font color=\"green\">up 43.7%</font> after hours, though its market value had dwindled over the past few years to just under $8M ($0.83/share).</li>    <li>The deal will result in a publicly traded company operating under Sonnet's name and a proposed Nasdaq ticker of SONN. Chanticleer will spin off its restaurant holdings into a new public company to be owned by current stockholders.</li>    <li>\"Fred, Patrick, Troy and I continue to be optimistic in the direction of our Better Burger business and the success of the numerous initiatives we have taken as a company thus far in 2019 to enhance delivery, technology, customer loyalty and the focus of building a leading culture for our employees,\" says Chanticleer CEO Mike Pruitt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505167\" data-linked=\"Hooters parent shifts into cancer research via reverse merger\" data-tweet=\"$BURG - Hooters parent shifts into cancer research via reverse merger https://seekingalpha.com/news/3505167-hooters-parent-shifts-cancer-research-via-reverse-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3505167-hooters-parent-shifts-cancer-research-via-reverse-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505165\" data-ts=\"1570744862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JELD\" target=\"_blank\">JELD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505165-jeld-wenminus-9_6-amid-early-results-trimmed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JELD-WEN -9.6% amid early results, trimmed guidance</a></h4><ul>    <li>JELD-WEN (NYSE:<a href='https://seekingalpha.com/symbol/JELD' title='JELD-WEN Holding, Inc.'>JELD</a>) is <font color=\"red\">9.6% lower</font> postmarket after the company cut its full-year revenue guidance and offered preliminary Q3 numbers.</li>    <li>For Q3, net revenues are coming in at about $1.09B (down 3.9% Y/Y), and EBITDA at $106M-$110M vs. a year-ago $132.6M.</li>    <li>\u201cI am disappointed in our preliminary results for the third quarter, primarily driven by soft demand in North America and further deterioration in housing activity in Australasia,\u201d says CEO Gary Michel.</li>    <li>More complete guidance will come during its earnings call Nov. 6, but the company says it now expects full-year revenue to drop about 2% Y/Y, and for EBITDA margins to take a 60-bp negative impact.</li>    <li>The company's holding a <a href=\"http://investors.jeld-wen.com\" target=\"_blank\">conference call</a> at 8 a.m. ET tomorrow to discuss the preliminary results.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505165\" data-linked=\"JELD-WEN -9.6% amid early results, trimmed guidance\" data-tweet=\"$JELD - JELD-WEN -9.6% amid early results, trimmed guidance https://seekingalpha.com/news/3505165-jeld-wenminus-9_6-amid-early-results-trimmed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505165-jeld-wenminus-9_6-amid-early-results-trimmed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505162\" data-ts=\"1570744319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505162-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a> <font color=\"green\">+3.9%</font>. <a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a> <font color=\"green\">+3.7%</font>. <a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a> <font color=\"green\">+3.5%</font>. <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"green\">+2.9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JELD' title='JELD-WEN Holding, Inc.'>JELD</a> <font color=\"red\">-9.5%</font>. <a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color=\"red\">-3.4%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals, Inc.'>ARWR</a> <font color=\"red\">-1.9%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color=\"red\">-1.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505162\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AERI $SAVE $ROKU - After Hours Gainers / Losers https://seekingalpha.com/news/3505162-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505162-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505160\" data-ts=\"1570743003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505160-trade-deskplus-2_4-rbc-upgrades-after-pullback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk +2.4% as RBC upgrades after pullback</a></h4><ul>   <li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) is <font color=\"green\">up 2.4%</font> postmarket as RBC's Mark Mahaney upgraded to Outperform.</li>    <li>He's pointing to solid fundamentals and a heavy decline since a July 1 downgrade, where the firm said it would \"become constructive again on a material stock pullback.\"</li>    <li>The Trade Desk is <font color=\"red\">off 33%</font> from its July 26 high. It's still <font color=\"green\">up 60%</font> YTD and is 36% below its intraday 52-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505160\" data-linked=\"Trade Desk +2.4% as RBC upgrades after pullback\" data-tweet=\"$TTD - Trade Desk +2.4% as RBC upgrades after pullback https://seekingalpha.com/news/3505160-trade-deskplus-2_4-rbc-upgrades-after-pullback?source=tweet\" data-url=\"https://seekingalpha.com/news/3505160-trade-deskplus-2_4-rbc-upgrades-after-pullback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505159\" data-ts=\"1570742625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDT\" target=\"_blank\">IDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505159-idtminus-3_4-revenues-income-fall-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IDT -3.4% as revenues, income fall in Q4</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> is <font color=\"red\">3.4% lower</font> postmarket following <a href=\"https://seekingalpha.com/news/3505136-idt-corporation-reports-q4-results\" target=\"_blank\">Q4 earnings</a> where revenues dipped and net income tumbled on a GAAP basis.</li>    <li>Revenues dropped 9.3% to $356.1M, and the company swung to an operating loss of $1.2M from a year-ago gain of $10.5M.</li>    <li>Attributable net income fell to $1.6M from $8.2M, and EBITDA dropped to $7.4M from $16.8M.</li>    <li>Non-GAAP net income was more than halved, to $4.1M from $9.8M.</li>    <li>The company pointed to metrics in its growth initiatives -- net2phone's Unified Communications-as-a-Service hit the 100,000-seat milestone; National Retail Solutions operated 7,800 active terminals in its retail POS network; and BOSS Revolution international money transfer processed more than 1M transactions for the quarter.</li>    <li>\"As expected, revenue from our core Carrier Services and BOSS Revolution Calling offerings continued to decrease as a result of industry-wide headwinds in the paid minute communications market, but the company-wide margin impact was dampened by increased contributions from our growth initiatives,\" says CEO Shmuel Jonas.</li>    <li><a href=\"http://ir.idt.net\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17659955-idt-corporation-reports-fourth-quarter-full-fiscal-year-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3505159\" data-linked=\"IDT -3.4% as revenues, income fall in Q4\" data-tweet=\"$IDT - IDT -3.4% as revenues, income fall in Q4 https://seekingalpha.com/news/3505159-idtminus-3_4-revenues-income-fall-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3505159-idtminus-3_4-revenues-income-fall-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505156\" data-ts=\"1570741687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505156-exone-sinks-20-after-issuing-downside-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne sinks 20% after issuing downside Q3 guidance</a></h4><ul><li>ExOne (NASDAQ:<a href='https://seekingalpha.com/symbol/XONE' title='The ExOne Company'>XONE</a>) <font color=\"red\">-19.7%</font> after-hours following a trading halt after <a href=\"https://seekingalpha.com/pr/17659904-exone-revises-third-quarter-full-year-2019-revenue-expectations-announces-financial-results\" target=\"_blank\">lowering Q3 revenue guidance</a> to $10M-$11M, compared with its prior expectation for revenue to rise \"modestly\" from $15.3M reported in Q2 and Q3 analyst consensus of $16.7M.</li><li>The company also now sees FY revenue growth coming in lower than previous guidance in the mid-teen percentage range.</li><li>XONE says it was unable to finalize installation of five machine projects  located at customer facilities, valued at ~$5M,  which would have contributed to meeting its Q3 goal; the company expects the projects will be completed during Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505156\" data-linked=\"ExOne sinks 20% after issuing downside Q3 guidance\" data-tweet=\"$XONE - ExOne sinks 20% after issuing downside Q3 guidance https://seekingalpha.com/news/3505156-exone-sinks-20-after-issuing-downside-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505156-exone-sinks-20-after-issuing-downside-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505153\" data-ts=\"1570741419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505153-slack-active-users-top-12m-in-september\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack active users top 12M in September</a></h4><ul><li>Slack Technologies (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) says it's exceeded 12M <a href=\"https://seekingalpha.com/pr/17659906-daily-active-users-created-equal-work-fueled-true-engagement\" target=\"_blank\">active users </a>of Slack each day in September, up ~37% Y/Y.</li><li>Shares<font color=\"green\"> rise 0.8%</font> in after-hours trading, had risen as much as 2.0%.</li><li>Reports more than 6M paid seats.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505153\" data-linked=\"Slack active users top 12M in September\" data-tweet=\"$WORK - Slack active users top 12M in September https://seekingalpha.com/news/3505153-slack-active-users-top-12m-in-september?source=tweet\" data-url=\"https://seekingalpha.com/news/3505153-slack-active-users-top-12m-in-september\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505141\" data-ts=\"1570739906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505141-spirit-airlinesplus-3-after-unit-revenue-guide-tops-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit Airlines +3% after unit revenue guide tops expectations</a></h4><ul><li>Spirit Airlines (NYSE:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a>) gains after a positive guidance update.</li><li>The airline company sees Q3 unit revenue growth of -2% vs. prior guidance for a range of -3.5% to -2.5%.</li><li><a href=\"https://seekingalpha.com/filing/4662282\" target=\"_blank\">SEC Form 8-K</a></li><li>Shares of SAVE are <font color=\"green\">up 2.97%</font> AH to $35.00.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505141\" data-linked=\"Spirit Airlines +3% after unit revenue guide tops expectations\" data-tweet=\"$SAVE - Spirit Airlines +3% after unit revenue guide tops expectations https://seekingalpha.com/news/3505141-spirit-airlinesplus-3-after-unit-revenue-guide-tops-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3505141-spirit-airlinesplus-3-after-unit-revenue-guide-tops-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505132\" data-ts=\"1570739102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505132-rokuplus-2_7-rbc-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +2.7% as RBC boosts to Outperform</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) is <font color=\"green\">up 2.7%</font> in early after-hours trading following an upgrade to Outperform at RBC, from Sector Perform.</li>    <li>The firm set its price target to $155, implying 33.5% upside from today's close.</li>    <li>Sell-side analysts already rate the stock <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, while <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Neutral</a> and it has a <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3505132\" data-linked=\"Roku +2.7% as RBC boosts to Outperform\" data-tweet=\"$ROKU - Roku +2.7% as RBC boosts to Outperform https://seekingalpha.com/news/3505132-rokuplus-2_7-rbc-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3505132-rokuplus-2_7-rbc-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505124\" data-ts=\"1570738414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIN\" target=\"_blank\">KIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505124-european-advisory-group-backs-kindreds-mirataz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Kindred&#39;s Mirataz</a></h4><ul><li>The European Medicines Agency's Committee for Medicinal Products for Veterinary Use &#40;CVMP&#41; has adopted a <a href=\"https://seekingalpha.com/pr/17659827-kindred-biosciences-announces-positive-opinion-cvmp-european-union-mirataz-mirtazapine\" target=\"_blank\">positive opinion</a> recommending approval of Kindred Biosciences' (NASDAQ:<a href='https://seekingalpha.com/symbol/KIN' title='Kindred Biosciences, Inc.'>KIN</a>) Mirataz (mirtazapine transdermal ointment) for body weight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Shares up <font color=\"green\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505124\" data-linked=\"European advisory group backs Kindred&#39;s Mirataz\" data-tweet=\"$KIN - European advisory group backs Kindred&#39;s Mirataz https://seekingalpha.com/news/3505124-european-advisory-group-backs-kindreds-mirataz?source=tweet\" data-url=\"https://seekingalpha.com/news/3505124-european-advisory-group-backs-kindreds-mirataz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505123\" data-ts=\"1570738133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505123-pi-financial-starts-shopify-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PI Financial starts Shopify at Buy</a></h4><ul>   <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) closed <font color=\"green\">up 3.4%</font> today after earning an initiation from PI Financial at Buy.</li>    <li>The firm initiated coverage on a few software companies, mostly at Neutral: BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>), Constellation Software (<a href='https://seekingalpha.com/symbol/CNSWF' title='Constellation Software Inc.'>OTCPK:CNSWF</a>).</li>    <li>Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) got a Sell initiation, however; its shares <font color=\"red\">fell 0.5%</font> today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505123\" data-linked=\"PI Financial starts Shopify at Buy\" data-tweet=\"$SHOP $BB $CNSWF - PI Financial starts Shopify at Buy https://seekingalpha.com/news/3505123-pi-financial-starts-shopify-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3505123-pi-financial-starts-shopify-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505114\" data-ts=\"1570737515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PUMP\" target=\"_blank\">PUMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505114-propetroplus-20-analysts-see-trouble-after-weak-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ProPetro +20% but analysts see trouble after weak outlook</a></h4><ul><li>ProPetro (<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a> <font color='green'>+19.5%</font>) shares bounce big from yesterday's all-time low, as analysts cite investor relief that the company indicated it <a href=\"https://seekingalpha.com/news/3504879-propetro-unveils-management-shakeup-internal-probe\" target=\"_blank\">would not restate prior financial results</a> following its review of accounting deficiencies; however, shares are still ~60% below their April peak.</li><li>PUMP also said it expected to idle as much as 28% of its hydraulic fracturing fleets in the current quarter compared to last quarter, citing customer spending cuts and softening industry demand, and several analysts <a href=\"https://www.reuters.com/article/us-propetro-investigation/analysts-cut-propetro-price-targets-after-oil-services-firm-issues-weak-outlook-idUSKBN1WP2PH\" target=\"_blank\">cut their Q4 earnings and share price outlooks</a> as a result.</li><li>\"We were expecting more like a 10% reduction\" in fleet utilization, says AltaCorp Capital's Waqar Syed, while adding investors were relieved that co-founder Dale Redman would remain with the company because \"he brings a lot of value to the company because of his relationships.\"</li><li>Cowen analysts say PUMP's weaker frack fleet utilization implied pre-tax earnings for the quarter of ~$75M, below Wall Street's $102M consensus estimate.</li><li>Raymond James cuts its stock price target to $14 from a previous target of $20, while others also lower their targets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505114\" data-linked=\"ProPetro +20% but analysts see trouble after weak outlook\" data-tweet=\"$PUMP - ProPetro +20% but analysts see trouble after weak outlook https://seekingalpha.com/news/3505114-propetroplus-20-analysts-see-trouble-after-weak-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3505114-propetroplus-20-analysts-see-trouble-after-weak-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505111\" data-ts=\"1570737239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARPO\" target=\"_blank\">ARPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505111-aerpio-down-8-on-underwhelming-early-stage-akb0978-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aerpio down 8% on underwhelming early-stage AKB0978 data</a></h4><ul><li>Thinly traded nano cap Aerpio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARPO' title='Aerpio Pharmaceuticals, Inc.'>ARPO</a> <font color=\"red\">-8%</font>) is down on triple normal volume, albeit on turnover of only 208K shares, in apparent reaction to <a href=\"https://seekingalpha.com/pr/17659735-aerpio-pharmaceuticals-announces-interim-results-phase-1b-clinical-trial-topical-ocular\" target=\"_blank\">preliminary data</a> from a Phase 1b study evaluating eye drop candidate AKB-9778 for the potential treatment of primary open-angle glaucoma &#40;POAG&#41;.</li><li>Although the primary endpoint is safety, initial pharmacodynamic results showed a peak reduction in intraocular pressure &#40;IOP&#41; of -1.47 mmHg four hours after the administration of the highest daily dose that was maintained for eight hours, but the effect returned to baseline levels 24 hours post dose (administered on the last day of a seven-day treatment period).</li><li>By comparison, results from Phase 3 studies showed that Aerie Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a> <font color=\"red\">-2%</font>) Rhopressa (netarsudil ophthalmic solution) lowered IOP by up to 5 mmHg on day 15 and ~2.5 - 4.0 mmHg on day 90.</li><li>Aerpio has amended the protocol to include patients with ocular hypertension and POAG. Complete results should be available in Q1 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505111\" data-linked=\"Aerpio down 8% on underwhelming early-stage AKB0978 data\" data-tweet=\"$ARPO $AERI - Aerpio down 8% on underwhelming early-stage AKB0978 data https://seekingalpha.com/news/3505111-aerpio-down-8-on-underwhelming-early-stage-akb0978-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3505111-aerpio-down-8-on-underwhelming-early-stage-akb0978-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505103\" data-ts=\"1570733947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INXN\" target=\"_blank\">INXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505103-interxionplus-5_5-amid-report-hired-bankers-for-offers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterXion +5.5% amid report it&#39;s hired bankers for offers</a></h4><ul>   <li>A leg up in InterXion (<a href=\"http://seekingalpha.com/symbol/INXN\" target=\"_blank\">INXN</a> <font color=\"green\">+5.5%</font>) this afternoon is credited to a report that the company is working with a banker on acquisition offers it's received, Cowen says.</li>    <li>The data-center firm, often discussed in M&amp;A talk, was cited by TMT Finance as talking with bankers to handle the offers.</li>    <li>While a deal may not come from the offers, Cowen's Colby Synesael says InterXion could be valued at a higher multiple than CyrusOne due to a higher return profile. He has an $84 price target, now implying 1.9% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505103\" data-linked=\"InterXion +5.5% amid report it&#39;s hired bankers for offers\" data-tweet=\"$INXN - InterXion +5.5% amid report it&#39;s hired bankers for offers https://seekingalpha.com/news/3505103-interxionplus-5_5-amid-report-hired-bankers-for-offers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505103-interxionplus-5_5-amid-report-hired-bankers-for-offers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505101\" data-ts=\"1570733389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505101-fsct-inxn-and-lpl-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FSCT, INXN and LPL among tech movers</a></h4><ul><li><strong>Gainers: </strong>Schmitt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a>) <font color=\"green\">+22%</font>. Sunnova Energy International (NYSE:<a href='https://seekingalpha.com/symbol/NOVA' title='Sunnova Energy International Inc.'>NOVA</a>) <font color=\"green\">+6%</font>.  RADCOM (NASDAQ:<a href='https://seekingalpha.com/symbol/RDCM' title='RADCOM Ltd.'>RDCM</a>) <font color=\"green\">+6%</font>.  LG Display (NYSE:<a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a>) <font color=\"green\">+6%</font>.  InterXion Holding N.V. (NYSE:<a href='https://seekingalpha.com/symbol/INXN' title='InterXion Holding N.V.'>INXN</a>) <font color=\"green\">+5%</font>.</li> <li><strong>Losers: </strong>Forescout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>) <font color=\"red\">-35%</font>. ADTRAN (NASDAQ:<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a>) <font color=\"red\">-20%</font>. USA Technologies (<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>OTC:USAT</a>) <font color=\"red\">-12%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"red\">-12%</font>. Tufin Software Technologies (NYSE:<a href='https://seekingalpha.com/symbol/TUFN' title='Tufin Software Technologies Ltd.'>TUFN</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505101\" data-linked=\"FSCT, INXN and LPL among tech movers\" data-tweet=\"$SMIT $NOVA $RDCM - FSCT, INXN and LPL among tech movers https://seekingalpha.com/news/3505101-fsct-inxn-and-lpl-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505101-fsct-inxn-and-lpl-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505100\" data-ts=\"1570732726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505100-allegheny-tech-tapped-buy-on-valuation-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech tapped as a Buy on valuation at Goldman</a></h4><ul><li>Allegheny Technologies (<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color='green'>+5.4%</font>) jumps after Goldman Sachs <a href=\"https://thefly.com/thestreet/realmoney/index.php/ATIid2973665/ATI-Allegheny-Technologies-upgraded-to-Buy-from-Neutral-at-Goldman-Sachs\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $25 price target, saying ATI is one of few stocks in the specialty metals sector with sales growth that does not depend on a commodity price recovery.</li><li>Goldman's Matthew Korn thinks the stock's  valuation discount created by softness in certain secondary end-markets  and uncertainty created by the 737 MAX grounding has created a buying  opportunity.</li><li>Korn says the fundamental driver of ATI's growth - growing  global demand for modern jet engines that require highly technical  specialty metal components - remains intact.</li><li>ATI's average <a href=\"https://seekingalpha.com/symbol/ATI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505100\" data-linked=\"Allegheny Tech tapped as a Buy on valuation at Goldman\" data-tweet=\"$ATI - Allegheny Tech tapped as a Buy on valuation at Goldman https://seekingalpha.com/news/3505100-allegheny-tech-tapped-buy-on-valuation-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3505100-allegheny-tech-tapped-buy-on-valuation-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505096\" data-ts=\"1570731561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRC\" target=\"_blank\">HRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505096-hill-rom-down-3-on-expected-revenue-earnings-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hill-Rom down 3% on expected revenue/earnings pressure</a></h4><ul><li>Thinly traded Hill-Rom Holdings (<a href='https://seekingalpha.com/symbol/HRC' title='Hill-Rom Holdings, Inc.'>HRC</a> <font color=\"red\">-3%</font>) is down on 33% higher volume, albeit on turnover of only 509K shares, on the heels of a cautious note from Stifel.</li><li>Analyst Rick Wise (BUY/$115) believes the company's 2020 revenues and earnings will be \"slightly pressured\" from its <a href=\"https://seekingalpha.com/news/3476765-hillrom-sell-surgical-consumable-products-170m\" target=\"_blank\">divestment </a>of certain of its surgical consumables (deal completed in August) which eliminated $100M in sales and $0.20 in EPS on a full-year pro forma basis and acquisition-related dilution.</li><li>HRC says the divestiture will trim ~$0.15 from 2020 EPS and the Breathe Technology <a href=\"https://seekingalpha.com/news/3486388-hillrom-acquires-breathe-technologies-130m\" target=\"_blank\">acquisition</a> will cut another $0.05. It will release fiscal Q4 results on November 1.</li><li>Mr. Wise adds that 2020 EPS may be shy of the company's goal of double-digit core growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505096\" data-linked=\"Hill-Rom down 3% on expected revenue/earnings pressure\" data-tweet=\"$HRC - Hill-Rom down 3% on expected revenue/earnings pressure https://seekingalpha.com/news/3505096-hill-rom-down-3-on-expected-revenue-earnings-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/3505096-hill-rom-down-3-on-expected-revenue-earnings-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505093\" data-ts=\"1570730683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBTYA\" target=\"_blank\">LBTYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505093-iss-advises-opposition-of-sunrises-upc-switzerland-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISS advises opposition of Sunrise&#39;s UPC Switzerland deal</a></h4><ul>   <li>Proxy adviser ISS has recommended that Sunrise Communications shareholders vote against the acquisition of Liberty Global's (<a href=\"http://seekingalpha.com/symbol/LBTYA\" target=\"_blank\">LBTYA</a> <font color=\"red\">-3.5%</font>) Swiss unit, adding fuel to top Sunrise holder Freenet's (<a href='https://seekingalpha.com/symbol/FRTAY' title='Freenet AG ADR'>OTC:FRTAY</a>) attempt to stop the deal.</li>    <li>Long-term benefits of the 6.3B Swiss-franc deal aren't obvious, ISS says, \"as cable\u2019s competitiveness vis-a-vis fibre and 5G is questionable,\" even if there's a strategic advantage in the short to mid-term.</li>    <li>This week, Sunrise chief Olaf Swantee reiterated his <a href=\"https://seekingalpha.com/news/3504557-sunrise-chief-charges-forward-upc-deal-plans\" target=\"_blank\">commitment to push the deal through</a>, saying \"I don't have a plan B.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505093\" data-linked=\"ISS advises opposition of Sunrise&#39;s UPC Switzerland deal\" data-tweet=\"$LBTYA $FRTAY $LBTYA - ISS advises opposition of Sunrise&#39;s UPC Switzerland deal https://seekingalpha.com/news/3505093-iss-advises-opposition-of-sunrises-upc-switzerland-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3505093-iss-advises-opposition-of-sunrises-upc-switzerland-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505091\" data-ts=\"1570730442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505091-propetro-and-falcon-minerals-among-energy-materials-gainers-kraton-and-centrus-energy-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ProPetro and Falcon Minerals among Energy/Materials gainers; Kraton and Centrus Energy among losers</a></h4><ul><li><b>Gainers: </b>ProPetro (NYSE:<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a>) <font color=\"green\">+20%</font>. Falcon Minerals (NASDAQ:<a href='https://seekingalpha.com/symbol/FLMN' title='Falcon Minerals Corporation'>FLMN</a>) <font color=\"green\">+11%</font>. NexGen Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/NXE' title='NexGen Energy Ltd.'>NXE</a>) <font color=\"green\">+7%</font>. Hudbay Minerals (NYSE:<a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc.'>HBM</a>) <font color=\"green\">+7%</font>. Hallador Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/HNRG' title='Hallador Energy Company'>HNRG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Kraton (NYSE:<a href='https://seekingalpha.com/symbol/KRA' title='Kraton Corporation'>KRA</a>) <font color=\"red\">-30%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"red\">-19%</font>. Endeavour Silver (NYSE:<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a>) <font color=\"red\">-9%</font>. SM Energy (NYSE:<a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a>) <font color=\"red\">-8%</font>. Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505091\" data-linked=\"ProPetro and Falcon Minerals among Energy/Materials gainers; Kraton and Centrus Energy among losers\" data-tweet=\"$PUMP $FLMN $NXE - ProPetro and Falcon Minerals among Energy/Materials gainers; Kraton and Centrus Energy among losers https://seekingalpha.com/news/3505091-propetro-and-falcon-minerals-among-energy-materials-gainers-kraton-and-centrus-energy-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3505091-propetro-and-falcon-minerals-among-energy-materials-gainers-kraton-and-centrus-energy-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505089\" data-ts=\"1570729887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORM\" target=\"_blank\">FORM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505089-formfactorplus-2-amid-deal-to-buy-frt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FormFactor +2% amid deal to buy FRT</a></h4><ul>   <li>FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) is <font color=\"green\">up 2%</font> today after announcing its deal to <a href=\"https://seekingalpha.com/pr/17658306-formfactor-acquires-frt-gmbh\" target=\"_blank\">acquire Germany metrology supplier FRT</a>.</li>    <li>The company's paying \u20ac19.7M in cash, with up to \u20ac10.3M in additional cash consideration possible based on 2020 performance.</li>    <li>That acquisition expands FormFactor's addressable market by $150M, the company says.</li>    <li>FRT's revenues have expanded at more than a 75% compounded annual growth rate since its inception in 2016.</li>    <li>The deal is expected to be immediately accretive to earnings on a non-GAAP basis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505089\" data-linked=\"FormFactor +2% amid deal to buy FRT\" data-tweet=\"$FORM - FormFactor +2% amid deal to buy FRT https://seekingalpha.com/news/3505089-formfactorplus-2-amid-deal-to-buy-frt?source=tweet\" data-url=\"https://seekingalpha.com/news/3505089-formfactorplus-2-amid-deal-to-buy-frt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505083\" data-ts=\"1570728365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505083-hexo-stumble-pressures-pot-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexo stumble pressures pot stocks</a></h4><ul><li>Cannabis producers Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"red\">-11%</font>), Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"red\">-5.2%</font>), Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a> <font color=\"red\">-5.4%</font>), Aphria (<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"red\">-9.4%</font>) and Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"red\">-8.2%</font>) are under pressure as investors react to Hexo's significant <a href=\"https://seekingalpha.com/news/3504959-hexo-21-percent-premarket-soft-preliminary-revenue-withdrawal-2020-outlook\" target=\"_blank\">downward adjustment</a> to its fiscal Q4 revenue outlook. It also withdrew its previous guidance of up to $400M in revenue for fiscal 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505083\" data-linked=\"Hexo stumble pressures pot stocks\" data-tweet=\"$TLRY $ACB $CRON - Hexo stumble pressures pot stocks https://seekingalpha.com/news/3505083-hexo-stumble-pressures-pot-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3505083-hexo-stumble-pressures-pot-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>129&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505082\" data-ts=\"1570727427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505082-teva-sells-logistics-center-for-127m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva sells logistics center for $127M</a></h4><ul><li>Advancing its turnaround plan that includes the divestment of a range of assets, Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"green\">+1.5%</font>) has <a href=\"https://www.fiercepharma.com/pharma/teva-sheds-logistics-center-for-127m-after-2-years-2-about-faces\" target=\"_blank\">agreed to sell</a> its Shoham-based 50,000 sq. ft. logistics center to real estate outfit Amot Investments for NIS 445M ($127M).</li><li>The company will continue to use the center via a lease through subsidiary Salomon, Levin and Elstein &#40;SLE&#41;, the current owner. Under the terms of the deal, SLE will rent the site for 10 years at NIS 22M per annum, after which Teva could continue renting for up to 24 years and 11 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505082\" data-linked=\"Teva sells logistics center for $127M\" data-tweet=\"$TEVA - Teva sells logistics center for $127M https://seekingalpha.com/news/3505082-teva-sells-logistics-center-for-127m?source=tweet\" data-url=\"https://seekingalpha.com/news/3505082-teva-sells-logistics-center-for-127m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505077\" data-ts=\"1570726933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505077-allegheny-technologies-among-industrial-gainers-nuverra-environmental-solutions-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Technologies among industrial gainers; Nuverra Environmental Solutions among losers</a></h4><ul><li><b>Gainers: </b>Tecogen (NASDAQ:<a href='https://seekingalpha.com/symbol/TGEN' title='Tecogen Inc.'>TGEN</a>) <font color=\"green\">+16%</font>. Allegheny Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a>) <font color=\"green\">+6%</font>. RADA Electronic Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/RADA' title='RADA Electronic Industries Ltd.'>RADA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-22%</font>. Nuverra Environmental Solutions (NYSEMKT:<a href='https://seekingalpha.com/symbol/NES' title='Nuverra Environmental Solutions, Inc.'>NES</a>) <font color=\"red\">-13%</font>. Select Interior Concepts (NASDAQ:<a href='https://seekingalpha.com/symbol/SIC' title='Select Interior Concepts, Inc.'>SIC</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505077\" data-linked=\"Allegheny Technologies among industrial gainers; Nuverra Environmental Solutions among losers\" data-tweet=\"$TGEN $ATI $RADA - Allegheny Technologies among industrial gainers; Nuverra Environmental Solutions among losers https://seekingalpha.com/news/3505077-allegheny-technologies-among-industrial-gainers-nuverra-environmental-solutions-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505077-allegheny-technologies-among-industrial-gainers-nuverra-environmental-solutions-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505076\" data-ts=\"1570726642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505076-gainers-none-mtr-and-iipr-only-financial-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gainers none, MTR and IIPR the only financial losers</a></h4><ul><li><b>Gainers:</b> None.</li><li><b>Losers:</b> Mesa Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/MTR' title='Mesa Royalty Trust'>MTR</a>) <font color=\"red\">-10%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505076\" data-linked=\"Gainers none, MTR and IIPR the only financial losers\" data-tweet=\"$MTR $IIPR - Gainers none, MTR and IIPR the only financial losers https://seekingalpha.com/news/3505076-gainers-none-mtr-and-iipr-only-financial-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505076-gainers-none-mtr-and-iipr-only-financial-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505071\" data-ts=\"1570726157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505071-oversold-freeport-mcmoran-upped-to-buy-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Oversold&#39; Freeport McMoRan upped to Buy at UBS</a></h4><ul><li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+5.7%</font>) surges after UBS <a href=\"https://www.thestreet.com/investing/freeport-hits-mother-lode-as-analyst-boosts-copper-mining-giant-15122341\" target=\"_blank\">upgrades shares to Buy</a> from Neutral rating with a $12 price target, saying investors are missing the bigger picture of long-term growth potential in favor of a short-term focus on the impact from lower copper prices.</li><li>FCX shares are \"oversold\" after dropping steadily over the past three weeks, UBS analyst Andreas Bokkenheuser says.</li><li>FCX's \"disproportionally high\" gold exposure and 10% compound annual production growth should help the stock outperform its peers, the firm says, which also sees the direction of copper prices - with which FCX is ~85% correlated - moving to the upside heading into 2020-22.</li><li>FCX's average <a href=\"https://seekingalpha.com/symbol/FCX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, and its <a href=\"https://seekingalpha.com/symbol/FCX/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> is Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505071\" data-linked=\"&#39;Oversold&#39; Freeport McMoRan upped to Buy at UBS\" data-tweet=\"$FCX - &#39;Oversold&#39; Freeport McMoRan upped to Buy at UBS https://seekingalpha.com/news/3505071-oversold-freeport-mcmoran-upped-to-buy-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3505071-oversold-freeport-mcmoran-upped-to-buy-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505068\" data-ts=\"1570725512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505068-bbby-fsct-pcg-and-rarx-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY, FSCT, PCG and RARX among midday movers</a></h4><ul><li><strong>Gainers</strong>: Ra Pharmaceuticals, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a>) <font color=\"green\">+100%</font>. OncoSec Medical Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) <font color=\"green\">+34%</font>. ProPetro Holding Corp. (NYSE:<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a>) <font color=\"green\">+22%</font>. Mereo BioPharma Group plc (NASDAQ:<a href='https://seekingalpha.com/symbol/MREO' title='Mereo BioPharma Group plc'>MREO</a>) <font color=\"green\">+21%</font>. Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+20%</font>. Caladrius Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a>) <font color=\"green\">+19%</font>. Danaos Corporation (NYSE:<a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a>) <font color=\"green\">+18%</font>. Bloom Energy Corporation (NYSE:<a href='https://seekingalpha.com/symbol/BE' title='Bloom Energy Corporation'>BE</a>) <font color=\"green\">+15%</font>. Falcon Minerals Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/FLMN' title='Falcon Minerals Corporation'>FLMN</a>) <font color=\"green\">+14%</font>. Tecogen Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/TGEN' title='Tecogen Inc.'>TGEN</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers</strong>: Forescout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>) <font color=\"red\">-36%</font>. Infrastructure and Energy Alternatives (NASDAQ:<a href='https://seekingalpha.com/symbol/IEA' title='Infrastructure and Energy Alternatives, Inc.'>IEA</a>) <font color=\"red\">-30%</font>. PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-29%</font>. Kraton (NYSE:<a href='https://seekingalpha.com/symbol/KRA' title='Kraton Corporation'>KRA</a>) <font color=\"red\">-28%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-25%</font>. HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"red\">-22%</font>. ADTRAN (NASDAQ:<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a>) <font color=\"red\">-21%</font>. Dogness (NASDAQ:<a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation'>DOGZ</a>) <font color=\"red\">-20%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"red\">-18%</font>. Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505068\" data-linked=\"BBBY, FSCT, PCG and RARX among midday movers\" data-tweet=\"$RARX $ONCS $PUMP - BBBY, FSCT, PCG and RARX among midday movers https://seekingalpha.com/news/3505068-bbby-fsct-pcg-and-rarx-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505068-bbby-fsct-pcg-and-rarx-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505066\" data-ts=\"1570725394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505066-usa-technologiesminus-11-after-restated-results-equity-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Technologies -11% after restated results, equity offer</a></h4><ul>   <li>USA Technologies (<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>OTC:USAT</a>) is <font color=\"red\">11.1% lower</font> after an <a href=\"https://seekingalpha.com/news/3504891-usa-technologies-reports-fy-results\" target=\"_blank\">earnings report</a> that worked to catch up on restatements alongside the company's discounted equity sale as part of a <a href=\"https://seekingalpha.com/news/3504876-usa-technologies-50m-financing-commitment\" target=\"_blank\">financing commitment</a>.</li>    <li>Along with fiscal-year results for the FYs ending June 30, 2019 and June 30, 2018, the company restated results for the fiscal year ended June 30, 2017; restated selected data for the years ended June 30, 2015 and June 30, 2016; and restated results for several quarters.</li>    <li>The company is guiding to fiscal 2020 revenue of $165M-$175M, below one estimate for $197.7M, and EBITDA of $10M-$11M.</li>    <li>It also expects net new service connections at 170,000-190,000.</li>    <li>The news has led Craig-Hallum to reinstate the company at a Buy after a \"painful\" year; it's set its price target at $10, now implying 56% upside.</li>    <li><a href=\"https://seekingalpha.com/pr/17658421-usa-technologies-reports-fiscal-year-2019-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3505066\" data-linked=\"USA Technologies -11% after restated results, equity offer\" data-tweet=\"$USAT - USA Technologies -11% after restated results, equity offer https://seekingalpha.com/news/3505066-usa-technologiesminus-11-after-restated-results-equity-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3505066-usa-technologiesminus-11-after-restated-results-equity-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505065\" data-ts=\"1570725066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505065-pg-and-e-plunges-on-fears-new-bankruptcy-plan-wipe-out-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E plunges on fears that new bankruptcy plan could wipe out shareholders</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"red\">-28.3%</font>) shares sink to their lowest level since January in the wake of <a href=\"https://seekingalpha.com/news/3504883-pg-and-e-minus-28-percent-bankruptcy-judge-decision-clearing-way-elliott-plan\" target=\"_blank\">yesterday's court ruling</a> that threatens to put the utility's fate in the hands of outsiders and perhaps wipe out the stock.</li><li>The ruling paves the way for a group led by Elliott Management that has devised a plan that \"could win and completely wipe out current shareholders,\" says Evercore ISI analyst Greg Gordon. \"In other words, <a href=\"https://finance.yahoo.com/news/pg-e-plunges-fear-total-134303593.html\" target=\"_blank\">zero is possible</a>.\"</li><li>Citigroup analysts <a href=\"https://www.streetinsider.com/Analyst+Comments/Citi+Downgrades+PG%26E+Corporation+%28PCG%29+to+Sell%2C+Sees+Potential+for+Equity+to+Hit+%240/15998937.html\" target=\"_blank\">downgrade the stock to Sell</a> from Neutral, saying the value could potentially plunge to zero, while Morgan Stanley <a href=\"https://thefly.com/thestreet/realmoney/index.php/PCGid2973939/PCG-PGE-ruling-raises-uncertainty-in-bankruptcy-process-says-Morgan-Stanley\" target=\"_blank\">maintains its Equal Weight rating</a>, apparently showing more faith in PG&amp;E's ability to negotiate with wildfire victims groups and build support for its own plan.</li><li>The stock drop coincides with PG&amp;E's planned power cuts to hundreds of thousands of homes and businesses; overnight, the utility said it <a href=\"https://www.wsj.com/articles/california-power-outage-rolls-into-second-day-millions-without-electricity-11570718584\" target=\"_blank\">began the second phase of the shutdown</a>, adding 234K customers including residents living in cities such as San Jose, Oakland and Berkeley to 513K customers in northern California, including in wine country where wildfires raged in 2017.</li><li>PG&amp;E says the shutdown eventually could affect as many as 2M Californians, and customers likely <a href=\"https://www.nbcnews.com/news/us-news/pg-e-slammed-cutting-power-millions-californians-n1064481\" target=\"_blank\">would not be reimbursed</a> for  lost business, housing alternatives or spoiled food and medicines.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505065\" data-linked=\"PG&amp;E plunges on fears that new bankruptcy plan could wipe out shareholders\" data-tweet=\"$PCG - PG&amp;E plunges on fears that new bankruptcy plan could wipe out shareholders https://seekingalpha.com/news/3505065-pg-and-e-plunges-on-fears-new-bankruptcy-plan-wipe-out-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3505065-pg-and-e-plunges-on-fears-new-bankruptcy-plan-wipe-out-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505064\" data-ts=\"1570724692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505064-stocks-hit-pause-after-morning-surge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks hit pause after morning surge</a></h4><ul><li>Stocks recede from session highs reached after President Trump tweeted that<a href=\"https://seekingalpha.com/news/3505011-stocks-get-jolt-trump-tweets-china-meeting\" target=\"_blank\"> he'll me meeting</a> with Chinese Vice Premier Liu He tomorrow at the White House.</li><li>The S&amp;P 500<font color=\"green\"> advances 0.8% </font>compared with its 1.0% gain earlier. The Nasdaq and Dow are each <font color=\"green\">up 0.7%</font>. Bonds fall, pushing Treasury yields up.</li><li>That follows a see-sawing <a href=\"https://seekingalpha.com/news/3504895-wild-overnight-trade-rumors-fly\" target=\"_blank\">futures market overnight</a> as conflicting rumors abounded on what the next developments in the U.S.-China trade situation would be.</li><li>\"There's some cause for optimism there, but it does seem to be a very fluid situation,\" Steven Violin, a portfolio manager at F.L. Putnam Investment Management, told the Wall Street Journal. \"It's been a true roller coaster... The winds seem to change daily.\"</li><li>Among S&amp;P 500 industry sectors, financials (<font color=\"green\">+1.7%</font>) and materials (<font color=\"green\">+1.2%</font>) lead the broader markets, while utilities (<font color=\"red\">-0.2%</font>) and real estate (<font color=\"green\">+0.1%</font>) lag.</li><li>10-year Treasury yield gains 8 basis points to 1.663%, its highest level since Sept. 30.</li><li>Crude oil <font color=\"green\">rises 1.5% </font>to $53.39 per barrel.</li><li>Gold falls below the $1,500 per ounce mark, <font color=\"red\">slipping 0.9%</font> to $1,499.90.</li><li>Dollar Index <font color=\"red\">slides 0.5% </font>to 98.67.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505064\" data-linked=\"Stocks hit pause after morning surge\" data-tweet=\"Stocks hit pause after morning surge https://seekingalpha.com/news/3505064-stocks-hit-pause-after-morning-surge?source=tweet\" data-url=\"https://seekingalpha.com/news/3505064-stocks-hit-pause-after-morning-surge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505061\" data-ts=\"1570723789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505061-puma-bio-down-6-on-sanders-callout-on-nerlynx-price-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puma Bio down 6% on Sanders callout on Nerlynx price hike</a></h4><ul><li>Puma Biotechnology (<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color=\"red\">-5.5%</font>) is down, albeit on below-average volume, in apparent response to <a href=\"https://twitter.com/sensanders?lang=en\" target=\"_blank\">disparaging comments</a> on Twitter from Presidential hopeful Sen. Bernie Sanders (I-VT) about its 20% price hike on breast cancer med Nerlynx (neratinib).</li></ul><div class=\"tiny-share-widget\" data-id=\"3505061\" data-linked=\"Puma Bio down 6% on Sanders callout on Nerlynx price hike\" data-tweet=\"$PBYI - Puma Bio down 6% on Sanders callout on Nerlynx price hike https://seekingalpha.com/news/3505061-puma-bio-down-6-on-sanders-callout-on-nerlynx-price-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3505061-puma-bio-down-6-on-sanders-callout-on-nerlynx-price-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505060\" data-ts=\"1570723507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505060-vodafone-pursues-135m-in-german-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone pursues \u20ac135M in German job cuts</a></h4><ul>    <li>Vodafone's (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"green\">+2.1%</font>) German division is set to cut up to \u20ac135M in costs for staffing, according to media reports, as part of its integration of Liberty Global's Unitymedia.</li>    <li>Those savings should be realized over the next two years, though it's not clear how many job cuts will come out of the 16,000 workers.</li>    <li>Unitymedia <a href=\"https://seekingalpha.com/news/3484945-liberty-global-closes-19b-asset-sale-vodafone\" target=\"_blank\">went to Vodafone</a> along with other Eastern European Liberty Global assets in July.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505060\" data-linked=\"Vodafone pursues \u20ac135M in German job cuts\" data-tweet=\"$VOD - Vodafone pursues \u20ac135M in German job cuts https://seekingalpha.com/news/3505060-vodafone-pursues-135m-in-german-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3505060-vodafone-pursues-135m-in-german-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505058\" data-ts=\"1570723387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505058-complement-system-players-see-uptick-in-buying-on-ra-pharma-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Complement system players see uptick in buying on Ra Pharma deal</a></h4><ul><li>UBS' <a href=\"https://seekingalpha.com/news/3504914-ucb-agrees-buy-ra-pharma-2_5b\" target=\"_blank\">$2.5B takeout</a> of Ra Pharmaceuticals appears to have stoked modest buying in Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color=\"green\">+2.4%</font>) and Apellis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color=\"green\">+6.6%</font>), both active in autoimmune disorders.</li><li>Ra Pharma's lead candidate is zilucoplan, in late-stage development for an autoimmune disorder called myasthenia gravis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505058\" data-linked=\"Complement system players see uptick in buying on Ra Pharma deal\" data-tweet=\"$ALXN $APLS - Complement system players see uptick in buying on Ra Pharma deal https://seekingalpha.com/news/3505058-complement-system-players-see-uptick-in-buying-on-ra-pharma-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3505058-complement-system-players-see-uptick-in-buying-on-ra-pharma-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505055\" data-ts=\"1570723221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505055-purple-innovation-and-viomi-technology-in-consumer-gainers-nio-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Purple Innovation and Viomi Technology in consumer gainers; NIO among losers</a></h4><ul><li><b>Gainers: </b>Purple Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/PRPL' title='Purple Innovation, Inc.'>PRPL</a>) <font color=\"green\">+8%</font>. Viomi Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/VIOT' title='Viomi Technology Co., Ltd'>VIOT</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Koninklijke Philips (NYSE:<a href='https://seekingalpha.com/symbol/PHG' title='Koninklijke Philips N.V.'>PHG</a>) <font color=\"red\">-9%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-8%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505055\" data-linked=\"Purple Innovation and Viomi Technology in consumer gainers; NIO among losers\" data-tweet=\"$PRPL $VIOT $PHG - Purple Innovation and Viomi Technology in consumer gainers; NIO among losers https://seekingalpha.com/news/3505055-purple-innovation-and-viomi-technology-in-consumer-gainers-nio-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505055-purple-innovation-and-viomi-technology-in-consumer-gainers-nio-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505043\" data-ts=\"1570720882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505043-american-outdoor-brands-bid-up-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Outdoor Brands bid up again</a></h4><ul> <li>American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='green'>+3.1%</font>) is adding to yesterday's pop which was sparked by an <a href=\"https://seekingalpha.com/news/3504679-american-outdoor-brands-plus-7-percent-catching-upgrade\" target=\"_blank\">upgrade</a> from Craig-Hallum.</li> <li>Despite the two-day rally, shares are down 48% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505043\" data-linked=\"American Outdoor Brands bid up again\" data-tweet=\"$AOBC - American Outdoor Brands bid up again https://seekingalpha.com/news/3505043-american-outdoor-brands-bid-up-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3505043-american-outdoor-brands-bid-up-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505041\" data-ts=\"1570720793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505041-equinor-expands-in-australia-new-exploration-permit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinor expands in Australia with new exploration permit</a></h4><ul><li>Equinor (<a href='https://seekingalpha.com/symbol/EQNR' title='Equinor ASA'>EQNR</a> <font color=\"green\">+3.4%</font>) says it <a href=\"https://www.rigzone.com/news/offshore_australia_permit_goes_to_equinor-10-oct-2019-160034-article/\" target=\"_blank\">won a new exploration permit</a> in the Northern Carnarvon Basin offshore Western Australia.</li><li>The acreage, which lies to the west of Santos' recent Dorado oil discovery, encompasses 1,859 sq. miles in water depths  of a much as 1,148 ft.; EQNR will be the operator and own a 100% interest  in the block.</li><li>Separately, Petrobras (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a>) says it signed a memorandum of understanding with EQNR to <a href=\"https://www.reuters.com/article/us-petrobras-equinor/petrobras-equinor-tie-up-for-natural-gas-projects-idUSKBN1WP00V\" target=\"_blank\">jointly develop Brazilian natural gas projects</a>.</li><li>The two companies already are partners in the Roncador oilfield and in several exploratory blocks.</li><li>Finally, the company says it <a href=\"https://www.offshoreenergytoday.com/equinor-cleared-for-norwegian-wells/\" target=\"_blank\">received consent</a> from Norway's Petroleum Safety  Authority to drill for three wells in the Barents Sea and another consent to drill a sidetrack in the North Sea.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505041\" data-linked=\"Equinor expands in Australia with new exploration permit\" data-tweet=\"$EQNR $PBR - Equinor expands in Australia with new exploration permit https://seekingalpha.com/news/3505041-equinor-expands-in-australia-new-exploration-permit?source=tweet\" data-url=\"https://seekingalpha.com/news/3505041-equinor-expands-in-australia-new-exploration-permit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505038\" data-ts=\"1570720125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADTN\" target=\"_blank\">ADTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505038-adtranminus-20-customer-slowdown-lands-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adtran -20% as customer slowdown lands in Q3</a></h4><ul>   <li>Adtran (NASDAQ:<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a>) has <font color=\"red\">tumbled 20.2%</font> after posting <a href=\"https://seekingalpha.com/news/3504903-adtran-announces-preliminary-3q19-estimates\" target=\"_blank\">preliminary Q3 estimates</a> that warned of substantial slowdowns at two \"Tier 1 customers\" -- Telmex (where it's pausing shipments) and Deutsche Telekom.</li>    <li>The company expects revenues will be about $114M, well below expectations for $140.3M, and EPS at -$0.06 vs. consensus for $0.03.</li>    <li>That's led holdout MKM to drop the company's last Buy rating, to Neutral. Analyst Michael Genovese says the stock's now a \"show-me story that could take time to bring many investors back from the sidelines.\" Deutsche Telekom and Telmex were 10% customers for Adtran in Q2, he notes.</li>    <li>He's cut his price target to $11 from $17 (now implying 26% upside after today's slide).</li>    <li>Needham is sticking with its Hold rating and doesn't see a path to profitability to justify a better view yet.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505038\" data-linked=\"Adtran -20% as customer slowdown lands in Q3\" data-tweet=\"$ADTN - Adtran -20% as customer slowdown lands in Q3 https://seekingalpha.com/news/3505038-adtranminus-20-customer-slowdown-lands-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3505038-adtranminus-20-customer-slowdown-lands-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505036\" data-ts=\"1570719905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505036-financials-power-up-treasury-yields-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials power up as Treasury yields jump</a></h4><ul><li>Financials lead the broader market's advance, with the S&amp;P 500 financials sector <font color=\"green\">gaining 1.3%</font>.</li><li>Financial Select Sector SPDR ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>) <font color=\"green\">rises 1.5%</font> and the SPDR S&amp;P Bank ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>) <font color=\"green\">jumps 1.8%</font>.</li><li>Treasury yields moved up after President Trump<a href=\"https://seekingalpha.com/news/3505011-stocks-get-jolt-trump-tweets-china-meeting\" target=\"_blank\"> tweeted </a>that he'll be meeting with Chinese Vice Premier Lui He tomorrow at the White House, boosting hopes that they'll be some progress made in resolving the U.S.-China trade dispute.</li><li>10-year Treasury yield rises 6.5 basis points to 1.651%.</li><li>Financial names rising the most include: Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color=\"green\">+2.5%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color=\"green\">+2.6%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color=\"green\">+2.3%</font>), Deutsche Bank (<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank Aktiengesellschaft'>DB</a> <font color=\"green\">+2.4%</font>),  Capital One (<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a> <font color=\"green\">+2.2%</font>), Prudential Financial (<a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a> <font color=\"green\">+2.4%</font>), and AIG (<a href='https://seekingalpha.com/symbol/AIG' title='American International Group, Inc.'>AIG</a> <font color=\"green\">+2.4%</font>).</li><li>Investors may still be sifting through September Fed<a href=\"https://www.federalreserve.gov/monetarypolicy/fomcminutes20190731.htm\" target=\"_blank\"> meeting minutes</a>.  Amid the discussion, a \"few participants\" saw that financial markets were pricing in more \"accommodation\" than the Fed members saw as appropriate and the FOMC might need to better align market expectations with those of the policymakers.</li><li>Since the minutes were released, the <a href=\"https://www.cmegroup.com/trading/interest-rates/countdown-to-fomc.html\" target=\"_blank\">probability</a> for a 25 basis point rate cut at this month's FOMC meeting receded to 75.4% from 80.2% yesterday and 88.7% a week ago, according to the CME FedWatch Tool, which is based on trading of federal funds futures.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505036\" data-linked=\"Financials power up as Treasury yields jump\" data-tweet=\"$BAC $C $KEY - Financials power up as Treasury yields jump https://seekingalpha.com/news/3505036-financials-power-up-treasury-yields-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/3505036-financials-power-up-treasury-yields-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505031\" data-ts=\"1570719608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505031-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a>) <font color=\"green\">+101%</font>. OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) <font color=\"green\">+31%</font>. Stealth BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MITO' title='Stealth BioTherapeutics Corp'>MITO</a>) <font color=\"green\">+20%</font>. Mereo BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MREO' title='Mereo BioPharma Group plc'>MREO</a>) <font color=\"green\">+19%</font>. Foamix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals Ltd.'>FOMX</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers: </b>HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"red\">-24%</font>. Sundial Growers (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDL' title='Sundial Growers Inc.'>SNDL</a>) <font color=\"red\">-11%</font>. Akari Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) <font color=\"red\">-10%</font>. SmileDirectClub (NASDAQ:<a href='https://seekingalpha.com/symbol/SDC' title='SmileDirectClub, Inc.'>SDC</a>) <font color=\"red\">-9%</font>. OrganiGram (NASDAQ:<a href='https://seekingalpha.com/symbol/OGI' title='OrganiGram Holdings Inc.'>OGI</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505031\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$RARX $ONCS $MITO - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3505031-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505031-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505028\" data-ts=\"1570718897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505028-mosaic-cuts-potash-production-esterhazy-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mosaic cuts potash production at Esterhazy mine</a></h4><ul><li>Mosaic (<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a> <font color='green'>+2.9%</font>) says it will temporarily <a href=\"https://seekingalpha.com/pr/17658940-mosaic-announces-temporary-curtailment-esterhazy-potash-mine\" target=\"_blank\">curtail potash production</a> at its Esterhazy mine in Saskatchewan, citing rising inventories due to a short-term slowdown in global potash markets and increased risks of a delay in Chinese contract settlement.</li><li>When combined with a previously  announced cut, the move brings the company's total curtailments to as much as 600K metric tons.</li><li>MOS says the curtailments would lower adjusted EBITDA by $150M if the full amount is realized in lower Q4 sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505028\" data-linked=\"Mosaic cuts potash production at Esterhazy mine\" data-tweet=\"$MOS - Mosaic cuts potash production at Esterhazy mine https://seekingalpha.com/news/3505028-mosaic-cuts-potash-production-esterhazy-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3505028-mosaic-cuts-potash-production-esterhazy-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505025\" data-ts=\"1570717965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505025-macau-names-break-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau names break higher</a></h4><ul> <li>Macau casino stocks are perky with U.S. and China trade negotiations seeming to heat up at a higher level.</li> <li>There's also a positive note out from Nomura Instinet analyst Harry Curtis on the sector. Curtis says share prices already reflect the Q3 weakness and notes drivers for earnings in 2020 include the HKZM bridge, a relaxing of visa restrictions and GDP growth following a trade war resolution.</li> <li>MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+2%</font>), Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+3%</font>), Melco Resorts &amp; International (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited'>MLCO</a> <font color='green'>+1.8%</font>) and Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+2%</font>) are all ahead of broad market averages.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505025\" data-linked=\"Macau names break higher\" data-tweet=\"$MGM $WYNN $MLCO - Macau names break higher https://seekingalpha.com/news/3505025-macau-names-break-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3505025-macau-names-break-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505024\" data-ts=\"1570717825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505024-natural-gas-inventory-build-in-line-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build in-line with estimates</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+98 Bcf</strong> vs. +97 Bcf consensus, +112 Bcf last week.</li><li>Futures <font color=\"green\">+1.07%</font> to $2.258.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505024\" data-linked=\"Natural gas inventory build in-line with estimates\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build in-line with estimates https://seekingalpha.com/news/3505024-natural-gas-inventory-build-in-line-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3505024-natural-gas-inventory-build-in-line-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505022\" data-ts=\"1570717748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505022-qorvo-skyworks-jump-cowen-upgrades-on-2020-iphone-ramp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qorvo, Skyworks jump as Cowen upgrades on 2020 iPhone ramp</a></h4><ul>   <li>Cowen has upgraded key Apple suppliers Qorvo (<a href=\"http://seekingalpha.com/symbol/QRVO\" target=\"_blank\">QRVO</a> <font color=\"green\">+4.2%</font>) and Skyworks (<a href=\"http://seekingalpha.com/symbol/SWKS\" target=\"_blank\">SWKS</a> <font color=\"green\">+5%</font>) to Outperform on potential strength from a 5G iPhone.</li>    <li>Sentiment is low for this year's iPhone crop, analyst Karl Ackerman writes, ahead of anticipated 5G-enabled phones in the second half of 2020, which should provide a \"strong C2020 ramp in handset revenues.\"</li>    <li>He's raised his price target on Skyworks to $95 from $80, implying 12% upside, and raised the Qorvo target to $90 from $75, implying 18% upside.</li>    <li>Qorvo derives 32% of revenue from Apple, Bloomberg notes, while Skyworks derives 30% of revenue from key Apple supplier Foxconn.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505022\" data-linked=\"Qorvo, Skyworks jump as Cowen upgrades on 2020 iPhone ramp\" data-tweet=\"$QRVO $SWKS - Qorvo, Skyworks jump as Cowen upgrades on 2020 iPhone ramp https://seekingalpha.com/news/3505022-qorvo-skyworks-jump-cowen-upgrades-on-2020-iphone-ramp?source=tweet\" data-url=\"https://seekingalpha.com/news/3505022-qorvo-skyworks-jump-cowen-upgrades-on-2020-iphone-ramp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505021\" data-ts=\"1570717645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FREQ\" target=\"_blank\">FREQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505021-frequency-therapeutics-launches-mid-stage-study-of-hearing-loss-candidate-fxminus-322\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frequency Therapeutics launches mid-stage study of hearing loss candidate FX-322</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17658939-frequency-therapeutics-commences-dosing-phase-2a-study-fxminus-322-sensorineural-hearing-loss\" target=\"_blank\">Dosing is underway</a> in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT04120116?lead=frequency+therapeutics&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2a clinical trial</a> evaluating Frequency Therapeutics' (<a href='https://seekingalpha.com/symbol/FREQ' title='Frequency Therapeutics, Inc.'>FREQ</a> <font color=\"green\">+1.5%</font>) lead candidate FX-322 in patients with stable sensorineural hearing loss &#40;SNHL&#41; (the most common type).</li><li>The primary efficacy endpoints are three measures of hearing ability at day 210 compared to placebo. The estimated completion date is September 2020.</li><li>The company says <a href=\"https://www.frequencytx.com/pipeline-programs/hearing-program/\" target=\"_blank\">FX-322</a> is a small molecule designed to treat the underlying cause of SNHL by regenerating hair cells via the activation of progenitor cells in the cochlea (spiral cavity in the inner ear).</li></ul><div class=\"tiny-share-widget\" data-id=\"3505021\" data-linked=\"Frequency Therapeutics launches mid-stage study of hearing loss candidate FX-322\" data-tweet=\"$FREQ - Frequency Therapeutics launches mid-stage study of hearing loss candidate FX-322 https://seekingalpha.com/news/3505021-frequency-therapeutics-launches-mid-stage-study-of-hearing-loss-candidate-fxminus-322?source=tweet\" data-url=\"https://seekingalpha.com/news/3505021-frequency-therapeutics-launches-mid-stage-study-of-hearing-loss-candidate-fxminus-322\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505013\" data-ts=\"1570716263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTX\" target=\"_blank\">AKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505013-akaris-coversin-shows-positive-effect-in-mid-stage-pemphigoid-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akari&#39;s Coversin shows positive effect in mid-stage pemphigoid study</a></h4><ul><li>Akari Therapeutics (<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a> <font color=\"red\">-8.1%</font>) is down in early trade on the heels of the <a href=\"https://seekingalpha.com/pr/17659041-akari-therapeutics-announces-positive-phase-ii-clinical-data-orphan-blistering-skin-disease\" target=\"_blank\">release of data</a> from an ongoing Phase 2 clinical trial evaluating Coversin (nomacopan) in patients with a rare skin-blistering disorder called <a href=\"https://www.mayoclinic.org/diseases-conditions/bullous-pemphigoid/symptoms-causes/syc-20350414\" target=\"_blank\">bullous pemphigoid</a> &#40;BP&#41;. The results are being presented at the European Academy of Dermatology and Venereology Congress in Madrid.</li><li>On the safety front, daily doses of nomacopan were well-tolerated in six elderly subjects with no serious treatment-related adverse events.</li><li>Four of the six patients were classified at the upper limit of moderate BP (moderate-to-severe BP sufferers are most likely to benefit from reducing or eliminating steroid therapy). Treatment with nomacopan produced mean declines in BPDAI score (a measure of BP activity) of 41% at day 21 and 63% at day 42. Blister scores declined 59% and 68%, respectively. One of the two mild BP patients experienced a 100% decline in blisters by day 21 which was sustained to day 42.</li><li>Investors appear disappointed with the timeline for a pivotal study, expected to launch in H2 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505013\" data-linked=\"Akari&#39;s Coversin shows positive effect in mid-stage pemphigoid study\" data-tweet=\"$AKTX - Akari&#39;s Coversin shows positive effect in mid-stage pemphigoid study https://seekingalpha.com/news/3505013-akaris-coversin-shows-positive-effect-in-mid-stage-pemphigoid-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3505013-akaris-coversin-shows-positive-effect-in-mid-stage-pemphigoid-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504997\" data-ts=\"1570714173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504997-oncosecplus-34-premarket-after-strategic-deal-for-tavo-and-vla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoSec +34% premarket after strategic deal for TAVO and VLA</a></h4><ul><li>OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) is up <font color=\"green\">34%</font> premarket on <a href=\"https://seekingalpha.com/pr/17658957-oncosec-announces-30-million-usd-strategic-investment-premium-market-china-grand\" target=\"_blank\">entering</a> into a strategic transaction with Grand Decade Developments Limited, a direct, wholly-owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings, and its affiliate, Sirtex Medical US Holdings.</li> <li>OncoSec will receive a $30M investment from CGP and Sirtex at $2.50/share.</li><li>Upon the closing of this transaction, CGP and Sirtex together will hold 53% of OncoSec common shares and will be entitled to three of nine seats on the OncoSec Board of Directors.</li><li>OncoSec will grant Grand Decade and its affiliates an exclusive license to develop, manufacture, commercialize, or otherwise exploit OncoSec's current and future products, including TAVO and OncoSec's new Visceral Lesion Applicator &#40;VLA&#41;, in Greater China and 35 other Asian countries (the \"Territory\").</li><li>Grand Decade will pay up to 20% royalties on the net sales of such products in the Territory.</li><li>Sirtex will support and assist OncoSec with pre-marketing activities for TAVO and VLA in exchange for low single-digit royalties.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3504997\" data-linked=\"OncoSec +34% premarket after strategic deal for TAVO and VLA\" data-tweet=\"$ONCS - OncoSec +34% premarket after strategic deal for TAVO and VLA https://seekingalpha.com/news/3504997-oncosecplus-34-premarket-after-strategic-deal-for-tavo-and-vla?source=tweet\" data-url=\"https://seekingalpha.com/news/3504997-oncosecplus-34-premarket-after-strategic-deal-for-tavo-and-vla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504996\" data-ts=\"1570714101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LC\" target=\"_blank\">LC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504996-lendingclub-launches-digital-platform-day-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LendingClub launches digital platform with same-day settlement</a></h4><ul><li>LendingClub (NYSE:<a href='https://seekingalpha.com/symbol/LC' title='LendingClub Corporation'>LC</a>) <font color=\"green\">jumps 1.6%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17659205-lendingclub-launches-first-kind-digital-loan-transaction-platform-lcx\" target=\"_blank\">unveiling LCX</a>, an electronic marketplace designed to connect a broader array of institutional investors to its new digital platform and provide dynamic pricing and same-day settlement of fully funded whole loans.</li><li>LendingClub says the new platform also offers additional real-time insights on demand at the loan level, and provides the initial infrastructure needed for the development of a secondary market that will improve liquidity and value for this mainstream asset class.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504996\" data-linked=\"LendingClub launches digital platform with same-day settlement\" data-tweet=\"$LC - LendingClub launches digital platform with same-day settlement https://seekingalpha.com/news/3504996-lendingclub-launches-digital-platform-day-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3504996-lendingclub-launches-digital-platform-day-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504995\" data-ts=\"1570714057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IEA\" target=\"_blank\">IEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504995-infrastructure-and-energy-alternatives-merger-in-doubt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infrastructure and Energy Alternatives merger in doubt</a></h4><ul><li>Infrastructure and Energy Alternatives (NASDAQ:<a href='https://seekingalpha.com/symbol/IEA' title='Infrastructure and Energy Alternatives, Inc.'>IEA</a>) <font color=\"red\">-30%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17658274-infrastructure-energy-alternatives-inc-provides-update-recently-announced-potential\" target=\"_blank\">casting doubt on a potential merger</a>, which would include an additional investment from Ares Management (NYSE:<a href='https://seekingalpha.com/symbol/ARES' title='Ares Management Corporation'>ARES</a>).</li><li>IEA says it is now discussing \"an alternative transaction\" to the deal contemplated in August, which would include an additional investment in preferred stock by Ares but not a merger or any other going private transaction.</li><li>Recent equity financing has \"strengthened our balance sheet, significantly improved our liquidity and put us on solid footing to execute our 2019 business plan,\" IEA says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504995\" data-linked=\"Infrastructure and Energy Alternatives merger in doubt\" data-tweet=\"$IEA $ARES - Infrastructure and Energy Alternatives merger in doubt https://seekingalpha.com/news/3504995-infrastructure-and-energy-alternatives-merger-in-doubt?source=tweet\" data-url=\"https://seekingalpha.com/news/3504995-infrastructure-and-energy-alternatives-merger-in-doubt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504988\" data-ts=\"1570713362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504988-can-fite-up-5-premarket-on-publication-of-namodenoson-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite up 5% premarket on publication of namodenoson data</a></h4><ul><li>Thinly traded nano cap Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) is up <font color=\"green\">5% </font>premarket on light volume on the heels of the <a href=\"https://www.spandidos-publications.com/10.3892/ijmm.2019.4364\" target=\"_blank\">publication </a>of <a href=\"https://seekingalpha.com/pr/17658616-can-fite-announces-publication-namodenoson-nash-mechanism-action-international-journal\" target=\"_blank\">results </a>from a study evaluating namodenoson in an animal model of NASH in the <em>International Journal of Molecular Medicine. </em></li><li>The data showed that namodenson induced significant anti-inflammatory, anti-steatotic and anti-fibrotic effects based on its mediation of a cell-signaling pathway called Wnt/β-catenin.</li><li>A Phase 2 clinical trial is nearing completion. It is also being evaluated in a Phase 3 study in liver cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504988\" data-linked=\"Can-Fite up 5% premarket on publication of namodenoson data\" data-tweet=\"$CANF - Can-Fite up 5% premarket on publication of namodenoson data https://seekingalpha.com/news/3504988-can-fite-up-5-premarket-on-publication-of-namodenoson-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3504988-can-fite-up-5-premarket-on-publication-of-namodenoson-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504987\" data-ts=\"1570713228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504987-phg-pcg-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PHG, PCG among premarket losers</a></h4><ul><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-29%</font> on <a href=\"https://seekingalpha.com/news/3504883-pg-and-e-minus-28-percent-bankruptcy-judge-decision-clearing-way-elliott-plan\" target=\"_blank\">bankruptcy</a> judge decision clearing way for Elliott plan.</li><li>Forescout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>) <font color=\"red\">-26%</font> on <a href=\"https://seekingalpha.com/news/3504984-forescout-technologies-lowers-q3-guidance-shares-tank-28-percent-pm\" target=\"_blank\">preliminary</a> Q3 results.</li><li>HEXO (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"red\">-17%</font> on soft preliminary revenue and withdrawal of 2020 <a href=\"https://seekingalpha.com/news/3504959-hexo-21-percent-premarket-soft-preliminary-revenue-withdrawal-2020-outlook\" target=\"_blank\">outlook</a>.</li><li>Village Farms (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-12%</font> on bought deal <a href=\"https://seekingalpha.com/news/3504964-village-farms-minus-9-percent-premarket-bought-deal-common-stock-offering\" target=\"_blank\">stock offering</a>.</li><li>ADTRAN (NASDAQ:<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3504903-adtran-announces-preliminary-3q19-estimates\" target=\"_blank\">preliminary</a> Q3 results.</li><li>Koninklijke Philips (NYSE:<a href='https://seekingalpha.com/symbol/PHG' title='Koninklijke Philips N.V.'>PHG</a>) <font color=\"red\">-8%</font> as tariffs slam <a href=\"https://seekingalpha.com/news/3504953-philips-plunges-tariffs-slam-margin-goals\" target=\"_blank\">margin goals</a>.</li><li>Akari Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504987\" data-linked=\"PHG, PCG among premarket losers\" data-tweet=\"$PCG $FSCT $HEXO - PHG, PCG among premarket losers https://seekingalpha.com/news/3504987-phg-pcg-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3504987-phg-pcg-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504985\" data-ts=\"1570712907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504985-bbby-oncs-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY, ONCS among premarket gainers</a></h4><ul><li>Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a>) <font color=\"green\">+102%</font> on <a href=\"https://seekingalpha.com/news/3504914-ucb-agrees-buy-ra-pharma-2_5b\" target=\"_blank\">being acquired</a> by UCB SA.</li><li>OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) <font color=\"green\">+52%</font> on <a href=\"https://seekingalpha.com/pr/17658957-oncosec-announces-30-million-usd-strategic-investment-premium-market-china-grand\" target=\"_blank\">entering</a> into a strategic transaction with Grand Decade Developments</li><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+20%</font> after <a href=\"https://seekingalpha.com/news/3504931-bed-bath-and-beyond-soars-ceo-hire\" target=\"_blank\">CEO hire</a>.</li><li>ProPetro Holding (NYSE:<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3504879-propetro-unveils-management-shakeup-internal-probe\" target=\"_blank\">management shakeup</a> after internal probe.</li><li>Stealth BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MITO' title='Stealth BioTherapeutics Corp'>MITO</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3504950-alexion-teams-stealth-bio-advance-elamipretide\" target=\"_blank\">agreement</a> with Alexion Pharmaceuticals.<div> </div></li></ul><div class=\"tiny-share-widget\" data-id=\"3504985\" data-linked=\"BBBY, ONCS among premarket gainers\" data-tweet=\"$RARX $ONCS $BBBY - BBBY, ONCS among premarket gainers https://seekingalpha.com/news/3504985-bbby-oncs-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3504985-bbby-oncs-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504984\" data-ts=\"1570712878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSCT\" target=\"_blank\">FSCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504984-forescout-technologies-lowers-q3-guidance-shares-tank-28-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ForeScout Technologies lowers Q3 guidance; shares tank 28% PM</a></h4><ul><li>Forescout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='Forescout Technologies, Inc.'>FSCT</a>) <a href=\"https://seekingalpha.com/pr/17658965-forescout-technologies-announces-preliminary-third-quarter-2019-financial-results\" target=\"_blank\">expects</a> Q3 revenue in the range of $90.6 - $91.6M ($98.8 - 101.8M prior) vs. a consensus of $100.52M.</li><li>GAAP operating loss for the Q3 is expected to be in the range of $18.2 - $17.8M.</li><li>Non-GAAP operating loss for the quarter is expected to be in the range of $1.6 - $1.4M vs. Non-GAAP operating profit of $2.6 - $3.6M.</li><li>Shares <font color=\"red\">-28%</font> PM.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504984\" data-linked=\"ForeScout Technologies lowers Q3 guidance; shares tank 28% PM\" data-tweet=\"$FSCT - ForeScout Technologies lowers Q3 guidance; shares tank 28% PM https://seekingalpha.com/news/3504984-forescout-technologies-lowers-q3-guidance-shares-tank-28-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3504984-forescout-technologies-lowers-q3-guidance-shares-tank-28-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504981\" data-ts=\"1570712512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504981-amicus-up-6-premarket-on-preliminary-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus up 6% premarket on preliminary Q3 results</a></h4><ul><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) expects <a href=\"https://seekingalpha.com/pr/17658716-amicus-therapeutics-announces-preliminary-third-quarter-2019-revenue-financial-outlook-2019\" target=\"_blank\">Galafold sales</a> in Q3 to be ~$48M, up 133% from a year ago and above consensus of ~$45M.</li><li>It is raising the lower end of its full-year range for Galafold sales to $170M - 180M from $160M - 180M. It expects to end the year with more than $420M in cash which should extend its runway into H1 2022.</li><li>The webcast of its Analyst Day is currently underway.</li><li>Shares up <font color=\"green\">6%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504981\" data-linked=\"Amicus up 6% premarket on preliminary Q3 results\" data-tweet=\"$FOLD - Amicus up 6% premarket on preliminary Q3 results https://seekingalpha.com/news/3504981-amicus-up-6-premarket-on-preliminary-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3504981-amicus-up-6-premarket-on-preliminary-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504977\" data-ts=\"1570712485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504977-u-s-steel-jumps-after-trimming-q3-loss-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel jumps after trimming Q3 loss guidance</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color=\"green\">+2.6%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17658979-united-states-steel-corporation-provides-preliminary-third-quarter-2019-results\" target=\"_blank\">guiding for a Q3 adjusted loss of $0.20-$0.26</a>, an improvement from Sept. 18 guidance of a ~$0.35 loss and analyst consensus estimate of a $0.37 loss.</li><li>The company also guides for Q3 adjusted EBITDA of $134M-$144M, which excludes $54M of estimated restructuring charges, up from its previous outlook of $115M and $115.3M analyst consensus.</li><li>U.S. Steel says the improved outlook is due to stronger shipments and better than expected performance in its flat-rolled segment, as well as a contingency gain from recovered claims arising out of the bankruptcy of a supplier.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504977\" data-linked=\"U.S. Steel jumps after trimming Q3 loss guidance\" data-tweet=\"$X - U.S. Steel jumps after trimming Q3 loss guidance https://seekingalpha.com/news/3504977-u-s-steel-jumps-after-trimming-q3-loss-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3504977-u-s-steel-jumps-after-trimming-q3-loss-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504973\" data-ts=\"1570712277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRL\" target=\"_blank\">HRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504973-hormel-sets-profit-guidance-ahead-of-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hormel sets profit guidance ahead of consensus</a></h4><ul> <li>Hormel (NYSE:<a href='https://seekingalpha.com/symbol/HRL' title='Hormel Foods Corporation'>HRL</a>) updates guidance as part of the company's analyst day presentation.</li> <li>The new profit outlook is for full-year EPS of $1.76 to $1.80 vs. $1.71 to $1.85 prior and $1.74 consensus. Looking further down the road, Hormel sees 5% top line growth and 10% bottom line growth.</li> <li><a href=\"https://seekingalpha.com/filing/4661859\" target=\"_blank\">SEC Form 8-K</a></li> <li>Shares of Hormel are <font color=\"red\">down 0.21%</font> premarket to $42.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504973\" data-linked=\"Hormel sets profit guidance ahead of consensus\" data-tweet=\"$HRL - Hormel sets profit guidance ahead of consensus https://seekingalpha.com/news/3504973-hormel-sets-profit-guidance-ahead-of-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3504973-hormel-sets-profit-guidance-ahead-of-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504968\" data-ts=\"1570711597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MREO\" target=\"_blank\">MREO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504968-jefferies-softens-view-on-unitedhealth-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies softens view on UnitedHealth in premarket analyst action</a></h4><ul><li>Mereo Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MREO' title='Mereo BioPharma Group plc'>MREO</a>) initiated with Outperform rating and $8 (177% upside) price target at SVB Leerink.</li><li>BioCardia (<a href='https://seekingalpha.com/symbol/BCDA' title='BioCardia, Inc.'>OTCQB:BCDA</a>) initiated with Buy rating and $9 (169% upside) price target at Maxim Group.</li><li>AIM ImmunoTech (NYSEMKT:<a href='https://seekingalpha.com/symbol/AIM' title='AIM ImmunoTech Inc.'>AIM</a>) upgraded to Buy with a $2 (251% upside) price target at Maxim. Shares up <font color=\"green\">14%</font> premarket.</li><li>The Medicines Company (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a>) downgraded to Hold with a $50 (3% downside risk) price target at Jefferies. Shares down <font color=\"red\">3%</font> premarket.</li><li>UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a>) downgraded to Hold with a $235 (6% upside) price target at Jefferies. Shares down <font color=\"red\">1% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504968\" data-linked=\"Jefferies softens view on UnitedHealth in premarket analyst action\" data-tweet=\"$MREO $MDCO $UNH - Jefferies softens view on UnitedHealth in premarket analyst action https://seekingalpha.com/news/3504968-jefferies-softens-view-on-unitedhealth-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3504968-jefferies-softens-view-on-unitedhealth-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504967\" data-ts=\"1570711560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504967-hard-hats-on-for-netflix-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hard hats on for Netflix earnings</a></h4><ul> <li>Goldman Sachs drops its price target on Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) to $360 from $420 this morning.</li> <li>GS is just the latest firm to reel in near-term estimates on Netflix ahead of next week's earnings report and in advance of the launches of Disney+ and Apple TV+. Within the last few weeks, the list of firms lowering expectations includes Wells Fargo, Evercore ISI, Monness Crespi Hardt and Rosenblatt. Meanwhile, Seeking Alpha authors have a consensus <a href=\"https://seekingalpha.com/symbol/NFLX/ratings/author-ratings#filter=all\" target=\"_blank\">Neutral rating</a> on NFLX.</li> <li>Shares of Netflix are <font color=\"red\">down 1.11%</font> premarket to $264.56 to stand about 31% below the 52-week high of $385.99.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504967\" data-linked=\"Hard hats on for Netflix earnings\" data-tweet=\"$NFLX - Hard hats on for Netflix earnings https://seekingalpha.com/news/3504967-hard-hats-on-for-netflix-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3504967-hard-hats-on-for-netflix-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504964\" data-ts=\"1570711275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFF\" target=\"_blank\">VFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504964-village-farmsminus-9-premarket-on-bought-deal-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Village Farms -9% premarket on bought deal common stock offering</a></h4><ul> <li>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) has <a href=\"https://seekingalpha.com/pr/17658694-village-farms-international-announces-25-million-bought-deal-public-offering-common-shares\" target=\"_blank\">entered</a> into an agreement with a syndicate of underwriters pursuant to which the latter have agreed to purchase, on a bought deal basis, 2.66M common shares in the capital of the Company at $9.40/Offered Share for aggregate gross proceeds of C$25,004,000.</li> <li>Underwriters over-allotment is an additional 15% of the Offered Shares.</li> <li>Net proceeds will be used for working capital and general corporate purposes.</li><li>Closing date is October 22, 2019.</li><li>Shares are down<font color=\"red\"> 9%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3504964\" data-linked=\"Village Farms -9% premarket on bought deal common stock offering\" data-tweet=\"$VFF - Village Farms -9% premarket on bought deal common stock offering https://seekingalpha.com/news/3504964-village-farmsminus-9-premarket-on-bought-deal-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3504964-village-farmsminus-9-premarket-on-bought-deal-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504959\" data-ts=\"1570710757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEXO\" target=\"_blank\">HEXO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504959-hexo-down-21-premarket-on-soft-preliminary-revenue-withdrawal-of-2020-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexo down 21% premarket on soft preliminary revenue, withdrawal of 2020 outlook</a></h4><ul><li>Consumer cannabis package goods seller HEXO Corp. (NYSE:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) slumps <font color=\"red\">21%</font> premarket on modestly higher volume in response to less-than-expected <a href=\"https://seekingalpha.com/pr/17658595-hexo-corp-provides-preliminary-fourth-quarter-2019-revenue-results-withdraws-fiscal-year-2020\" target=\"_blank\">preliminary fiscal Q4 and fiscal 2019 results</a>.</li><li>Net revenue for FQ4 and F2019 should be $14.5M - 16.5M and $46.5M - 48.5M, respectively. During its FQ3 conference call, management projected a doubling of revenue in FQ4 ($31.8M based on FQ3). The shortfall was due to \"lower than expected product sell through.\"</li><li>Final FQ4 and F2019 results will be released on Thursday, October 24 before the open.</li><li>The company is also withdrawing its previously announced fiscal 2020 guidance of up to $400M in revenue.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504959\" data-linked=\"Hexo down 21% premarket on soft preliminary revenue, withdrawal of 2020 outlook\" data-tweet=\"$HEXO - Hexo down 21% premarket on soft preliminary revenue, withdrawal of 2020 outlook https://seekingalpha.com/news/3504959-hexo-down-21-premarket-on-soft-preliminary-revenue-withdrawal-of-2020-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3504959-hexo-down-21-premarket-on-soft-preliminary-revenue-withdrawal-of-2020-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504953\" data-ts=\"1570710241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHG\" target=\"_blank\">PHG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504953-philips-plunges-tariffs-slam-margin-goals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Philips plunges as tariffs slam margin goals</a></h4><ul><li>Philips (NYSE:<a href='https://seekingalpha.com/symbol/PHG' title='Koninklijke Philips N.V.'>PHG</a>) <font color=\"red\">-9.2%</font> pre-market after <a href=\"https://www.reuters.com/article/us-philips-results-warning/tariffs-take-toll-on-philips-margin-goal-in-blow-to-shares-idUSKBN1WP0IC\" target=\"_blank\">warning it will miss its 2019 profit margin target</a> due to increasing headwinds from tariffs causing poor results at its connected care unit, which suffered a 4.5-point decline in adjusted margin during Q3.</li><li>PHG's connected care business, which specializes in remote patient monitoring, is more exposed to tariffs than the company's two larger businesses,  which make hospital equipment such as medical scanners and personal  health products such as toothbrushes.</li><li>For the year, PHG expects margin improvement of 10-20 basis points, following three straight years of gains of at least 100 bps.</li><li>PHG also releases <a href=\"https://seekingalpha.com/pr/17658450-philips-provides-update-financial-performance-q3-2019\" target=\"_blank\">preliminary Q3 results</a>, which shows sales are expected to rise 6% to \u20ac4.7B and adjusted EBITA added 3% to \u20ac583M, or 12.4% of sales compared to 13.2% in the year-ago quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504953\" data-linked=\"Philips plunges as tariffs slam margin goals\" data-tweet=\"$PHG - Philips plunges as tariffs slam margin goals https://seekingalpha.com/news/3504953-philips-plunges-tariffs-slam-margin-goals?source=tweet\" data-url=\"https://seekingalpha.com/news/3504953-philips-plunges-tariffs-slam-margin-goals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504948\" data-ts=\"1570709268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRA\" target=\"_blank\">KRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504948-kraton-sees-adjusted-ebitda-10minus-15-below-lower-end-of-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kraton sees adjusted EBITDA 10%-15% below lower end of guidance</a></h4><ul><li>Kraton (NYSE:<a href='https://seekingalpha.com/symbol/KRA' title='Kraton Corporation'>KRA</a>) <font color=\"red\">-13.8%</font> pre-market after saying it now expects full-year adjusted EBITDA to come in <a href=\"https://seekingalpha.com/pr/17658710-kraton-corporation-provides-preliminary-third-quarter-2019-results-announces-third-quarter\" target=\"_blank\">10%-15% below the lower end</a> of its previous guidance range of $370M-$390M.</li><li>KRA says Q3 sales in its polymer business were hurt by continued deterioration in market demand in China and Asia due to tariffs and ongoing trade tensions, as well as weakening demand in Europe for automotive and compounding applications.</li><li>Q3 results in the chemical segment were hurt by an accelerated decline in  pricing for certain upgraded products in KRA's crude sulfate turpentine  chain and a 40% decline in global gum turpentine pricing.</li><li>KRA expects Q3 net income of $21M and adjusted EBITDA of $80M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504948\" data-linked=\"Kraton sees adjusted EBITDA 10%-15% below lower end of guidance\" data-tweet=\"$KRA - Kraton sees adjusted EBITDA 10%-15% below lower end of guidance https://seekingalpha.com/news/3504948-kraton-sees-adjusted-ebitda-10minus-15-below-lower-end-of-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3504948-kraton-sees-adjusted-ebitda-10minus-15-below-lower-end-of-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504946\" data-ts=\"1570708964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504946-netappminus-4_1-premarket-goldman-turns-bear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp -4.1% premarket as Goldman turns bear</a></h4><ul><li>NetApp (NASDAQ:<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>)<font color=\"red\"> sinks 4.1%</font> in premarket trading after Goldman double-cuts the stock to sell from buy, as analyst Rod Hall sees NetApp's outlook as \"hard to achieve.\"</li><li>Cuts price target to $45 from $61; average price target is $53.04.</li><li>Hall sees challenges for NetApp achieving its outlook in \"an environment where large enterprise spending appears to be deteriorating further.\"</li><li>Compares with Quant rating of<a href=\"https://seekingalpha.com/symbol/NTAP/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>; before this action, Sell-Side average rating was <a href=\"https://seekingalpha.com/symbol/NTAP/ratings/sell-side-ratings\" target=\"_blank\">Hold </a>(6 Buy, 2 Outperform, 18 Hold, 2 Underperform, 2 Sell).</li></ul><div class=\"tiny-share-widget\" data-id=\"3504946\" data-linked=\"NetApp -4.1% premarket as Goldman turns bear\" data-tweet=\"$NTAP - NetApp -4.1% premarket as Goldman turns bear https://seekingalpha.com/news/3504946-netappminus-4_1-premarket-goldman-turns-bear?source=tweet\" data-url=\"https://seekingalpha.com/news/3504946-netappminus-4_1-premarket-goldman-turns-bear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504936\" data-ts=\"1570707727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRNB\" target=\"_blank\">PRNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504936-principias-lead-candidate-shows-positive-action-in-second-stage-of-pemphigus-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Principia&#39;s lead candidate shows positive action in second stage of pemphigus study</a></h4><ul><li>Principia Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/PRNB' title='Principia Biopharma Inc.'>PRNB</a>) <a href=\"https://seekingalpha.com/pr/17658644-principia-announces-positive-preliminary-data-prn1008-ongoing-phase-2-part-b-trial-pemphigus\" target=\"_blank\">announces </a>positive preliminary data from Part B of its open-label <a href=\"https://clinicaltrials.gov/ct2/show/NCT02704429?lead=principia&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating lead candidate PRN1008 in pemphigus patients.</li><li>The complete response rate thus far is 40% (n=6/15) with four subjects remaining on treatment that will potentially be complete responders. Five participants were unable to achieve complete responses.</li><li>The safety profile was consistent with Part A.</li><li>In March, the company <a href=\"https://seekingalpha.com/news/3439525-principia-bios-lead-candidate-successful-mid-stage-pemphigus-study\" target=\"_blank\">announced </a>positive results from Part A of the study.</li><li>A Phase 3 trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03762265?lead=principia+biopharma&amp;phase=2&amp;rank=1\" target=\"_blank\">PEGASUS</a>, is in process.</li><li>PRN1008 is an optimized Bruton's tyrosine kinase &#40;BTK&#41; inhibitor that the company says enables rapid reversibility of effects on the immune system which makes it suitable for chronic therapy.</li><li>Management will host a conference call this morning at 8:00 am ET to discuss the results.</li><li>Shares up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504936\" data-linked=\"Principia&#39;s lead candidate shows positive action in second stage of pemphigus study\" data-tweet=\"$PRNB - Principia&#39;s lead candidate shows positive action in second stage of pemphigus study https://seekingalpha.com/news/3504936-principias-lead-candidate-shows-positive-action-in-second-stage-of-pemphigus-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3504936-principias-lead-candidate-shows-positive-action-in-second-stage-of-pemphigus-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504935\" data-ts=\"1570707655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504935-pure-storage-up-5_5-on-goldman-touch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Storage up 5.5% on Goldman touch</a></h4><ul><li>Goldman's Rod Hall is buying the bounce in Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage, Inc.'>PSTG</a>), upgrading to Buy from Neutral. His $21 price target suggests <font color=\"green\">28% upside</font> from last night's close.</li><li>Pure Storage had a rough spring/summer, bottoming at around $13.50 in mid-August. It's since moved to above $16 as of last night.</li><li>Shares are <font color=\"green\">up 5.5%</font> premarket to $17.26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504935\" data-linked=\"Pure Storage up 5.5% on Goldman touch\" data-tweet=\"$PSTG - Pure Storage up 5.5% on Goldman touch https://seekingalpha.com/news/3504935-pure-storage-up-5_5-on-goldman-touch?source=tweet\" data-url=\"https://seekingalpha.com/news/3504935-pure-storage-up-5_5-on-goldman-touch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504933\" data-ts=\"1570707416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504933-kroger-on-watch-after-jefferies-checks-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger on watch after Jefferies checks out</a></h4><ul> <li>Jefferies lowers Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a>) to a Hold rating from Buy on concerns over comparable sales growth.</li> <li>\"We\u2019re checking out as confidence in KR\u2019s [long-term] grocery strategy and mgmt\u2019s ability to effectively communicate wanes,\" says analyst Christopher Mandeville.</li> <li>The firm assigns a reduced price target of $26 v.s the sell-side consensus PT of <a href=\"https://seekingalpha.com/symbol/KR/ratings/sell-side-ratings?s=kr\" target=\"_blank\">$27.58</a>.</li> <li>Shares of Kroger are <font color=\"red\">down 1.34%</font> premarket to $24.20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504933\" data-linked=\"Kroger on watch after Jefferies checks out\" data-tweet=\"$KR - Kroger on watch after Jefferies checks out https://seekingalpha.com/news/3504933-kroger-on-watch-after-jefferies-checks-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3504933-kroger-on-watch-after-jefferies-checks-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504931\" data-ts=\"1570707062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504931-bed-bath-beyond-soars-after-ceo-hire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond soars after CEO hire</a></h4><ul> <li>The splashy CEO hire by Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) has drawn the attention of retail analysts.</li> <li>Several analysts have issued positive comments on Bed Bath &amp; Beyond <a href=\"https://seekingalpha.com/news/3504849-bed-bath-and-beyond-plus-15-percent-nabbing-target-exec\" target=\"_blank\">hiring</a> Target's CMO for the CEO job, while Telsey Advisory Group upgrades BBBY to an Outperform rating from Market Perform with the CEO overhang removed. Telsey's new price target of $16 is above the sell-side consensus PT of <a href=\"https://seekingalpha.com/symbol/BBBY/ratings/sell-side-ratings\" target=\"_blank\">$12.73</a>.</li> <li>Shares of Bed Bath &amp; Beyond are <font color=\"green\">up 21.43%</font> to $12.07.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504931\" data-linked=\"Bed Bath &amp; Beyond soars after CEO hire\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond soars after CEO hire https://seekingalpha.com/news/3504931-bed-bath-beyond-soars-after-ceo-hire?source=tweet\" data-url=\"https://seekingalpha.com/news/3504931-bed-bath-beyond-soars-after-ceo-hire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504925\" data-ts=\"1570706406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504925-hp-wilts-2_4-premarket-goldman-turns-bear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP wilts 2.4% premarket as Goldman turns bear</a></h4><ul><li>HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) <font color=\"red\">slides 2.4%</font> in premarket trading after Goldman Sachs  analyst Rod Hall cuts the stock to sell from neutral as he sees \"significant risk\" to earnings in the company's printing unit.</li><li>Trims price target to $14, a Street low, from $18; compares with average of $19.29.</li><li>\"Both PC and Printer demand are sensitive to macro conditions, which appear to be slowing,\" he writes.</li><li>Furthermore he expects that PC tailwinds will turn around during a \"difficult transition\" for its printing business.</li><li>Quant rating<a href=\"https://seekingalpha.com/symbol/HPQ/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>; SA Authors' average rating is<a href=\"https://seekingalpha.com/symbol/HPQ/ratings/author-ratings#filter=all\" target=\"_blank\"> Neutral</a> (2 Bullish, 5 Neutral).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3504191-hp-inc-loses-bull-amid-print-concerns\" target=\"_blank\">HP Inc. loses a bull amid print concerns</a> (Oct. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3504925\" data-linked=\"HP wilts 2.4% premarket as Goldman turns bear\" data-tweet=\"$HPQ - HP wilts 2.4% premarket as Goldman turns bear https://seekingalpha.com/news/3504925-hp-wilts-2_4-premarket-goldman-turns-bear?source=tweet\" data-url=\"https://seekingalpha.com/news/3504925-hp-wilts-2_4-premarket-goldman-turns-bear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504923\" data-ts=\"1570706182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504923-delta-dips-after-light-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta dips after light profit guidance</a></h4><ul> <li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) reports unit revenue was up 2.5% in <a href=\"https://seekingalpha.com/pr/17658658-delta-air-lines-announces-september-quarter-profit\" target=\"_blank\">Q3</a> off healthy leisure and corporate demand, while operating cost per available seat mile fell off 2.1%.</li> <li>Delta's operating revenue rose 6.5% to a quarterly record level of $12.6B. \"Strong demand and our customer-focused commercial initiatives are putting us on track to achieve a $3 billion increase in revenues this year, a pace of growth well in excess of GDP,\" notes Delta president Glen Hauenstein.</li> <li>Looking ahead, Delta sees Q4 EPS of $1.20 to $1.50 vs. $1.51 consensus and a pre-tax margin of 9.5% to 11.5%. Unit revenue is expected to rise 0% to 2% and operating cost per available seat mile is seen increasing 4% to 5%.</li> <li>Shares of Delta are <font color=\"red\">down 0.69%</font> premarket to $53.55.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3504919-delta-air-lines-eps-beats-0_05-misses-revenue\" target=\"_blank\">Delta Air Lines EPS beats by $0.05, misses on revenue</a> (Oct. 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3504923\" data-linked=\"Delta dips after light profit guidance\" data-tweet=\"$DAL - Delta dips after light profit guidance https://seekingalpha.com/news/3504923-delta-dips-after-light-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3504923-delta-dips-after-light-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504920\" data-ts=\"1570705408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRQR\" target=\"_blank\">PRQR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504920-proqrs-sepofarsen-shows-positive-action-in-phase-1-2-study-in-lca10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ProQR&#39;s sepofarsen shows positive action in Phase 1/2 study in LCA10</a></h4><ul><li>ProQR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics N.V.'>PRQR</a>) <a href=\"https://seekingalpha.com/pr/17658552-proqr-announces-positive-top-line-results-phase-1-2-study-sepofarsen-lca10-patients\" target=\"_blank\">announces </a>positive topline results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03140969?lead=proqr+therapeutics&amp;rank=4\" target=\"_blank\">Phase 1/2 clinical trial</a> evaluating sepofarsen (QR-110) in patients with Leber congenital amaurosis type 10 (LCA10) due to a certain mutation in the CEP290 gene.</li><li>The target dose (80 µg with a 160 µg loading dose) was associated with a clinically meaningful and statistically significant improvement in vision with a favorable benefit/risk profile. Durable improvements in vision were observed after six months of treatment.</li><li>A Phase 2/3 trial is in process.</li><li>Management will host a conference call this morning at 8:00 ET to discuss the results.</li><li>Shares are up <font color=\"green\">7%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504920\" data-linked=\"ProQR&#39;s sepofarsen shows positive action in Phase 1/2 study in LCA10\" data-tweet=\"$PRQR - ProQR&#39;s sepofarsen shows positive action in Phase 1/2 study in LCA10 https://seekingalpha.com/news/3504920-proqrs-sepofarsen-shows-positive-action-in-phase-1-2-study-in-lca10?source=tweet\" data-url=\"https://seekingalpha.com/news/3504920-proqrs-sepofarsen-shows-positive-action-in-phase-1-2-study-in-lca10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504914\" data-ts=\"1570704687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UCBJF\" target=\"_blank\">UCBJF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504914-ucb-agrees-to-buy-ra-pharma-for-2_5b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UCB agrees to buy Ra Pharma for $2.5B</a></h4><ul><li>UCB SA (<a href='https://seekingalpha.com/symbol/UCBJF' title='UCB SA'>OTCPK:UCBJF</a>) has <a href=\"https://seekingalpha.com/pr/17658454-ucb-agrees-acquire-ra-pharmaceuticals-joining-forces-improve-treatment-options-people-living\" target=\"_blank\">agreed to acquire</a> Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a>) for $48 per share in cash or $2.5B (\u20ac2.2B)($2.1B net of RARX cash).</li><li>UCB says the deal is consistent with its \"Accelerate and Expand\" strategy. In this case, it gains access to Ra's zilucoplan, in Phase 3 development for myasthenia gravis &#40;MG&#41;, complementing its own rozanolixizumab, also in late-stage development for MG.</li><li>Zilucoplan is also being evaluated in other complement-mediated disorders like ALS and immune-mediated necrotizing myopathy.</li><li>The transaction will not affect UCB's 2019 financial guidance. It will be dilutive to its mid-term earnings and will extend its mid-term goal of EBITDA/revenue of 31% out one year to 2022.</li><li>The deal should close by the end of Q1 2020.</li><li>RARX is up <font color=\"green\">106%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504914\" data-linked=\"UCB agrees to buy Ra Pharma for $2.5B\" data-tweet=\"$UCBJF $RARX $UCBJY - UCB agrees to buy Ra Pharma for $2.5B https://seekingalpha.com/news/3504914-ucb-agrees-to-buy-ra-pharma-for-2_5b?source=tweet\" data-url=\"https://seekingalpha.com/news/3504914-ucb-agrees-to-buy-ra-pharma-for-2_5b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3504895\" data-ts=\"1570692043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3504895-wild-overnight-trade-rumors-fly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wild overnight trade as rumors fly</a></h4><ul><li>Day traders are having a field day as headlines grab hold of market sentiment.</li><li>While U.S. stocks rallied Wednesday on trade optimism, futures <a href=\"https://seekingalpha.com/news/3504885-stock-futures-slide-chinese-report-stalled-talks\" target=\"_blank\">fell sharply</a> after the close on reports that U.S.-China trade talks - scheduled for today and tomorrow in Washington - might be cut short.</li><li>A volatile session then ensued, with futures now back at the starting line.</li><li>Among the rumors: There has been no change to the negotiation schedule, next week's tariff hike could be suspended, concessions may be announced for blacklisted Huawei, a currency pact is underway, a partial trade deal is in the works and Beijing is offering to increase agricultural purchases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3504895\" data-linked=\"Wild overnight trade as rumors fly\" data-tweet=\"Wild overnight trade as rumors fly https://seekingalpha.com/news/3504895-wild-overnight-trade-rumors-fly?source=tweet\" data-url=\"https://seekingalpha.com/news/3504895-wild-overnight-trade-rumors-fly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>147&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":73,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}